WO1993019599A1 - Herbicides - Google Patents

Herbicides Download PDF

Info

Publication number
WO1993019599A1
WO1993019599A1 PCT/GB1993/000542 GB9300542W WO9319599A1 WO 1993019599 A1 WO1993019599 A1 WO 1993019599A1 GB 9300542 W GB9300542 W GB 9300542W WO 9319599 A1 WO9319599 A1 WO 9319599A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
optionally substituted
alkyl
compound
composition
Prior art date
Application number
PCT/GB1993/000542
Other languages
French (fr)
Inventor
John Edward Duncan Barton
Keith Clinch
Peter John O'hanlon
John Charles Ormrod
Martin John Rice
Michael Drysdale Turnbull
Original Assignee
Zeneca Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929207542A external-priority patent/GB9207542D0/en
Priority claimed from GB929226733A external-priority patent/GB9226733D0/en
Application filed by Zeneca Limited filed Critical Zeneca Limited
Priority to EP93906681A priority Critical patent/EP0634895A1/en
Publication of WO1993019599A1 publication Critical patent/WO1993019599A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/04Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
    • A01N43/14Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings
    • A01N43/16Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings with oxygen as the ring hetero atom
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/04Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
    • A01N43/20Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom three- or four-membered rings
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/74Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,3
    • A01N43/761,3-Oxazoles; Hydrogenated 1,3-oxazoles
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N47/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
    • A01N47/08Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
    • A01N47/28Ureas or thioureas containing the groups >N—CO—N< or >N—CS—N<
    • A01N47/34Ureas or thioureas containing the groups >N—CO—N< or >N—CS—N< containing the groups, e.g. biuret; Thio analogues thereof; Urea-aldehyde condensation products
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings

Definitions

  • This invention relates to chemical compounds useful as herbicides, to processes for preparing them and to herbicidal compositions and processes utilising them.
  • a number of derivatives of monic acid are known to have utility as biologically active compounds for use in human and veterinary medicine. Such compounds are described inter alia in GB 1587058.
  • a herbicidal composition comprising a compound of the formula (I) or (IA) or (IB) in admixture with a herbicidally acceptable carrier or diluent, wherein Y represents (IC) or (ID) or (IE) and wherein R 2 is a group CO-XR 3 wherein X is O or S and R 3 is hydrogen or an agrochemically acceptable ester-forming radical; or R 2 is a group -R 4 wherein R 4 is an optionally substituted aryl or heterocyclic group; or R 2 is a group CO-NR 5 R 6 wherein R 5 and R 6 are the same or different and each represent an agrochemically acceptable
  • a process of severely damaging or killing unwanted plants which comprises applying to the plants, or to the growth medium of the plants, a herbicidally effective amount of a compound of the formula (I) or (IA) wherein Y represents (IC) or (ID) or (IE);
  • R 2 is a group CO-XR 3 wherein X is 0 or S and R 3 is hydrogen or an
  • R 2 is a group -R 4 wherein R 4 is an optionally substituted heterocyclic group; or R 2 is a group -CO-NH-CH 2 -CO-W wherein W is hydrogen, optionally substituted phenyl, optionally substituted C 1 to C 20 alkyl, optionally substituted C 2 to C 8 alkenyl, optionally substituted C 2 to C 8 alkynyl, optionally substituted heterocyclyl or C 3 to C 7 cycloalkyl; or
  • R 2 is a group -CO-NH-NH 2 or -CO-NH-NH-CO-Y wherein Y is optionally substituted C 1 to C 20 alkyl, optionally substituted C 2 to C 8 alkenyl, optionally substituted aryl, optionally substituted aralkyl or optionally substituted heterocyclyl; or
  • R 2 is a group CO-NR 5' R 6' wherein R 5' and R 6' are the same or different and each represent (a) hydrogen, or (b) C 1-20 alkyl, C 2-8 alkenyl, either of which may be optionally substituted with C 3-7 cycloalkyl, halogen, carboxy, C 1-6 alkoxycarbonyl, carbamyl, aryl, heterocyclyl, hydroxy, C 1-6
  • R 5' and R 6' together with the nitrogen atom to which they are attached represent an optionally substituted C 5-7 heterocyclic ring;
  • R 2 is a group -CO-O-R 7 wherein R 7 is a C 3-20 alkyl, C 3-8 cycloalkyl, C 4-20 alkenyl, aralkyl, cycloalkylalkyl, heterocyclyl or heterocyclylalkyl group which group is substituted with a ketonic oxo group; or R 7 is a group -CH 2 -COR 13 wherein R 13 is acyl, aralkyl, amino, ureido or carbamic acid ester residue,
  • aryl as used herein includes phenyl, and naphthyl
  • thioalkynyl hydroxy, cyano, nitro, amino, mono- and di- C 1-6 alkylamino, C 1-6 alkanesulphinyl, C 1-6 alkane sulphonyl, carboxy, C 1-6 alkoxycarbonyl, and C 1-6 alkoxycarbonyl(C 1-6 )alkyl groups.
  • aralkyl as used herein includes groups in which the aryl moiety is a phenyl group which may be optionally substituted as
  • heterocyclyl as used herein includes aliphatic or aromatic single or fused rings comprising up to four hetero atoms in the ring selected from oxygen, nitrogen and sulphur and optionally substituted with aryl, with another heterocyclic ring or with one or more of those
  • R 2 is a group CO-XR 3
  • X is preferably 0.
  • Suitable ester-forming radicals, R 3 include optionally substituted C 1 to C 20 alkyl, optionally substituted C 2 to C 20 , for example C 2 to C 8 alkenyl, optionally substituted C 2 to C 20 , for example C 2 to C 8 alkynyl, optionally substituted C 3 to C 7 cycloalkyl, optionally substituted aryl or optionally substituted heterocyclyl.
  • Optional substituents which may be present in optionally substituted alkyl, alkenyl or alkynyl groups, such as those represented by R 3 , include
  • Optional substituents which may be present in C 3-7 cycloalkyl groups include C 1-6 alkyl halo-C 1-6 alkyl and those substituents listed above in relation to alkyl, alkenyl and alkynyl groups.
  • R 3 is alkyl, optionally substituted by aryl it may be regarded as an aralkyl group as defined above.
  • Suitable ester-forming radicals R 3 also include C 1 to C 10 alkyl optionally substituted by hydroxy, halogen, cyano. Suitable ester-forming radicals R 3 also include C 2 to C 10 , for example C 2 to C 4 alkenyl, for example vinyl, prop-2-ene-1-yl, and but-1-ene-4-yl which may be
  • a further preferred group R 3 is a C 1-10 alkyl group, and preferably a C 1-4 alkyl group, substituted by a group -A-R 11 wherein A is 0 or a group S(O) x wherein x is 0, 1 or 2 and R 11 is an optionally substituted C 1 to
  • C 10 and preferably optionally substituted C 1-6 , for example C 1 to C 4 alkyl group, an optionally substituted C 2 to C 8 , and preferably optionally substitued C 2-6 , for example C 2 to C 4 alkenyl group, an optionally
  • substituted C 3-7 cycloalkyl group for example an optionally substituted C 3-6 cycloalkyl group, or an optionally substitututed C 3-7 heterocyclic group, for example an optionally substituted aliphatic heterocyclic group, for example an optionally substituted oxygen-containing aliphatic
  • A is preferably oxygen.
  • alkyl, alkenyl, alkynyl and aryl may be straight or branched chain groups.
  • Salts of the compound of formula (I) (IA) and (IB) wherein R 2 is the group CO-XR 3 and in which X is 0 and R 3 is hydrogen include for example metal salts, e.g. aluminium, alkali metal salts, such as sodium or
  • alkaline earth metal salts such as calcium or magnesium
  • ammonium or substituted ammonium salts for example those with lower alkyl-amino such as triethylamine, hydroxy-lower alkylamines such as
  • tri-(2-hydroxyethyl)-amine cycloalkylamines such as bicyclohexyl-amine, or with procaine, dibenzylamine, N,N-dibenzyl-ethylenediamine,
  • N-ethylpiperidine N-benzyl- ⁇ -phenethyl-amine, dehydroabietylamine
  • N,N'-bis-dehydroabietylethylenediamine or bases of the pyridine type (such as pyridine, collidine, or quinoline) or trimethylsulphonium.
  • R 4 is an optionally substituted heterocyclic ring of formula (III) wherein Y is 0 or S and R 14 and R 15 have the meanings given previously.
  • An especially preferred group R is an optionally substituted oxazol-2-yl group, for example a group of formula (IV) wherein R 14 has the meaning given previously.
  • R 4 may be a group of formula (IV) wherein R 14 is itself an optionally substituted heterocyclic group, for example a group of the formula (IVa), (IVb) or (IVc) in which formulae R16 , R 17 , and R 18 may be the same or different each is selected from hydrogen, halogen, optionally substituted (C 1-6 )alkyl, aryl, aralkyl, heterocyclyl, (C 1-6 )alkoxy, hydroxy, carboxy and salts thereof, (C 1-6 )alkoxycarbonyl, carbamoyl, mono- or di-(C 1-6 )alkylcarbamoyl, sulphamoyl, mono- and di-(C 1-6 )alkylsulphamoyl, cyano, nitro, amino, mono-and di-(C 1-6 )alkylamino, acylamino, ureido,
  • R 14 is a group of formula (IVc) and R 16 , R 17 and R 18 are preferably hydrogen.
  • a further suitable ester-forming radical R 3 is a group R 7 wherein R 7 represents an optionally substituted C 3-20 alkyl, for example C 3-10 alkyl, C 3-8 cycloalkyl, C 3-20 alkenyl, aralkyl, cycloalkylalkyl, heterocyclyl or heterocyclylalkyl group which group is additionally substituted with a ketonic oxo group.
  • one sub class of the group R 2 when it is a group -CO-OR 7 is a group of formula (V) wherein Z is an optionally substituted C 1 to C 12 alkylene group (-(CH 2 ) n ,,- wherein n" is from 1 to 12) and R 8 represents a
  • Optional substituents may be those specified above for the groups alkyl, cycloalkyl, alkenyl, aryl and heterocyclyl respectively.
  • a further sub-class of the group R 2 is a group CO-OR 7 and R 7 is a group -CH 2 -CO-R 13 wherein R 13 is suitably a carbamic acid ester residue.
  • carboxylate ester residue is meant a group of general formula -N(R 19 )-CO-NR 20 R 21 wherein R 19 is hydrogen or an optionally substitued C 1-6 alkyl group and R 20 and R 21 are independently selected from hydrogen or any of the groups R 5 and R 6 given below.
  • Suitable agrochemically acceptable amide-forming radicals R 5 and R 6 which may be the same or different, there may be mentioned:
  • substituted C 2- 2 0 for example C 2-8 alkenyl group or an optionally substituted C 2- 2 0 , for example C 2-8 alkynyl group or
  • R 5 is hydrogen and R 6 is a group -NR 22 -N 23 R 24 wherein R 22 is hydrogen or C 1-6 alkyl are R 23 and R 24 , which may be the same or different, may independently take any of the meanings given for R 5 and R 6 under (a), (b), (c), (d), (e) and (f) above or
  • R 5 is hydrogen and R 6 is a group -CR 25 R 26 -CO-W or - NR 27 -CO-W wherein W is optionally substituted phenyl or optionally substituted heterocyclyl, R 25 , R 26 and R 27 are indendently hydrogen or optionally substitued C 1-6 alkyl groups.
  • R 5 and R 6 are those wherein R 5 is hydrogen or a C 1-4 alkyl group and R 6 is a C 1-4 alkyl group, each of which alkyl groups may independently be optionally
  • R 5 and R 6 together with the nitrogen atom to which they are attached represent an optionally substituted C 5-6 aliphatic heterocyclic ring.
  • suitable groups wherein R 5 and R 6 together with the nitrogen atom to which they are attached form an
  • C 5-6 heterocyclic ring there may be mentioned morpholinyl, piperidyl, piperazinyl, or pyrollidinyl, each of which may be optionally substituted by halogen or C 1-4 alkyl.
  • R 5 is hydrogen and R 6 is a group -CR 25 R 26 -CO-W or - NR 27 -CO-W
  • R 25 , R 26 and R 27 are preferably hydrogen and W is preferably optionally substituted phenyl or an optionally substituted 5 or 6-membered
  • heterocyclic ring containing from 1 to 3 heteroatoms selected from oxygen, nitrogen and sulphur, for instance thienyl or furanyl.
  • Suitable substituents for W when it is a phenyl or heterocyclyl group include those mentioned previously and especially halogen, C 1 to C 6 alkyl, C 1 to C 6 alkoxy, hydroxy, carboxy, C 1 -C 6 alkoxycarbonyl, carbamoyl, mono-or di- (C 1 to C 6 ) alkyl carbamoyl, sulphamoyl, mono- and di-(C 1 to C 6 ) sulphamoyl, cyano, for example m- or p- cyano, nitro, amino, mono- and di- (C 1 to C 6 ) alkylamino, C 1 to C 6 acylamino, ureido, C 1 to C 6
  • alkoxycarbonylamino 2,2,2-trichloroethoxycarbonylamino, C 1 to C 6 alkanoyl, C 1 to C 6 alkylthio, C 1 to C 6 alkanesulphinyl, and C 1 to C 6 alkanesulphonyl.
  • a compound of the formula (I) or (IA) or (IB) above wherein R 2 is a group CO-XR 3 X, is 0 or S and R 3 is a C 1-10 alkyl group substituted by a group -A-R 11 wherein A is 0 or a group S(0) x wherein x is 0, 1 or 2 and R 11 is an optionally substituted C 1 to C 10 akyl group, an optionally
  • R 3 is not a group -(CH 2 ) 2 - when R 11 is ethyl.
  • Optional substituents may be those indicated previously as suitable for alkyl, alkenyl, alkynyl, phenyl, cycloalkyl or heterocyclyl
  • R 3 is a C 1-4 alkyl group substituted by a group -A-R 11 wherein A is 0 or a group S(0) x wherein x is 0, 1 or 2 and R 11 is an optionally substituted C 1 to C 6 akyl group, an optionally substituted C 2 to
  • R 3 is the group
  • n' is an integer from 1 to 4 A is 0 or a group S(0) wherein x is 0, 1 or 2 and R 12 is hydrogen or a C 1 to C 4 alkyl group.
  • Such compounds having the tri-substituted double bond in the E-configuration are referred to as monic acid C, monic acid A and monic acid B respectively.
  • the compounds of the present invention are derivatives of Monic acid A.
  • the compounds of the present invention may exist in the E (natural) and Z (or iso) geometrical forms in respect of the tri-substituted double bond.
  • the stereochemistry of the compound of formula (I) is thus preferably defined such that the moiety (VI) is that moiety having the trivial name "normonyl"
  • Table 2 lists examples of compounds for use in the composition of the present invention wherein the compound is of formula (IB), being derivatives of pseudomonic acid.
  • Table 3 lists examples of compound for use in the composition of the present invention wherein the compound is of formula (I) and Y is of formula (IC), being derivatives of monic acid C.
  • the compounds may be regarded as derivatives of monic acid which may be prepared by the selective hydrolysis of pseudomonic acid.
  • a further useful starting material is the ketone which may be obtained from
  • pseudomonic acid by ozonolysis at -50 to -80°C as described for example in GB 1587 060.
  • Derivatives of pseudomonic acid may of course be prepared directly for pseudomonic acid as starting material.
  • hydroxy groups In general it is desirable to protect the hydroxy groups during reactions of the the starting material such as monic acid or derivatives thereof or the corresponding ketone.
  • suitable protecting groups are silyl groups since these are readily removed under mild conditions. Such groups are introduced by conventional silylating agents, including halosilanes and silazanes.
  • the hydroxyl-protecting groups may subsequently be removed by methods known in the art, including enzymatic methods.
  • silyl protecting groups may generally be removed by mild acid hydrolysis followed by alkaline hydrolysis as described for example by J P Clayton, K Luk and N H Rogers in
  • the compound No 1 of Table 1 is a known compound and may be prepared for example as described above. A more detailed preparation is given in
  • Table 1 may also be prepared from monic acid by routine methods as described for example in GB 1,587,058. Typical processes include the reaction of monic acid with a base, for example a hydroxide, carbonate or bicarbonate of the desired cation followed by the removal of water; ion exchange with an appropriate resin; and reaction with amines.
  • a base for example a hydroxide, carbonate or bicarbonate of the desired cation followed by the removal of water; ion exchange with an appropriate resin; and reaction with amines.
  • Compound No 2 and Compound No 21 of Table 1 are known compounds and may be prepared for example as described in Examples 24 and 3 respectively of GB 1,587,059.
  • General methods of preparing compounds of formula (I) wherein R 2 is a group -COXR 3 and X is 0 and R 3 is an agrochemically acceptable ester-forming radical are also disclosed in GB 1,587,059.
  • Compound No 3 of Table 1 is a known compound and may be prepared for example using the general methods described in GB 1,587,059 or as more specifically described in J Antibiot. 198841(5).
  • Compound No 4 of Table 1 is a known compound and may be prepared for example using the methods disclosed in EP 0002 371 as more specifically disclosed in Example 5 thereof.
  • Compounds wherein R 2 in the compound of formula (I) is -CO-XR 3 and X is S may similarly be prepared using the general methods disclosed in EP 0002 371.
  • Compound Nos 6 and 7 of Table 1 are known compounds and may be prepared for example as described in EP 0025 288 and as more specifically described in Examples 2 and 5 thereof.
  • Compounds wherein R 2 in the compound of formula (I) is a group of formula -CO-O-R 7 and R 7 is a C 3-20 alkyl, C 3-8 cycloalkyl, C 4-20 alkenyl, aralkyl, cycloalkylalkyl,
  • heterocyclyl or heterocyclylalkyl group which group is substituted with a ketonic oxo group may be prepared using the general methods described in
  • Compound No 8 of Table 1 is a known compound and may be prepared for example using the methods disclosed in Japanese patent No 54-151132.
  • Compound No 10 of Table 1 is a known compound and may be prepared for example using the methods disclosed in EP 0052437, and as more
  • Patent No 54-12376 or EP 0052437 are examples of EP 0052437.
  • Compound No 14 of Table 1 is a known compound and may be prepared for example using the methods disclosed in EP 0087 953, and as more
  • heterocyclic group -R 4 having the formula (III) above which may similarly be prepared as described in EP 0087 953.
  • Compound No 19 may be prepared using an analogous method to that described in Example 14 of EP 0087 953 (5-methyl-2-(1-normon-2-yl)oxazole or as more specifically described in J Chem Soc, Perkin Trans. I 1989 (11) 2059-63.
  • Compound No 22 of Table 1 may be prepared as described in Example 10 of
  • Compound No 15 of Table 1 is a known compound and may be prepared for example using the methods disclosed in EP 0123378, and as more
  • Compound No 18 of Table 1 is a known compound and may be prepared for example using the methods disclosed in EP 0399 645, and as more
  • R 2 is a group -R 4 having the formula (II) above may be prepared using the general methods of EP 0399 645.
  • typical processes for the manufacture of compounds of formula (I), (IA) or (IB) wherein R 2 is the group -COOR 3 include the reaction of a salt of monic acid (A, B or C) or pseudomonic acid, for example an alkali metal salt, with a compound R 3 -L wherein L is a leaving group such as halogen or mesolate to form an ester.
  • the reaction suitably takes place in a solvent such as dimethylformamide or
  • dimethylsulphoxide at a temperature in the range 10°C to 100°C and optionally in the presence of a co-solvent such as
  • the salt of monic acid or pseudomonic acid may be prepared in situ, for example by treatment of the acid with the appropriate base such as the carbonate.
  • compounds of formula (I), (IA) or (IB) wherein R 2 is the group -COXR 3 or -CONR 5 R 6 may be prepared by the action of a compound R 3 XH or R 5 R 6 NH on a monic or pseudomonic acid or a simple activated derivative thereof.
  • the raction takes place in a solvent such as tetrahydrofuran, diethyl ether, dichloromethane or chloroform and at a temperature in the range from -10°C to 70°C.
  • the compounds for use in the compositions of the present invention are active against a broad range of weed species including monocotyledonous and dicotyledonous species. Many compounds show good selectivity in crops, particularly wheat, barley, maize, oil seed rape, sugar beet and rice.
  • the compounds for use in compositions of the present invention are preferably applied directly to unwanted plants (post-emergence application) but they may also be applied to the soil before the unwanted plants emerge
  • a process of severely damaging or killing unwanted plants which comprises applying to the plants or the the growth medium of the plants a herbicidally effective amount of a compound of the formula (I) or (IA) or (IB) as hereinbefore defined wherein R 2 is as hereinbefore defined.
  • Novel compounds of the present invention are preferably used in the form of a composition
  • a composition comprising a compound of formula (I) in admixture with a carrier comprising a solid or liquid diluent.
  • Suitable compositions of the present invention include both dilute compositions, which are ready for immediate use, and concentrated
  • compositions which require to be diluted before use, usually with water.
  • the compositions contain from 0.01% to 90% by weight of the active ingredient.
  • Dilute compositions ready for use preferably contain from 0.01 to 2% of active ingredient, while concentrated compositions may contain from 20 to 90% of active ingredient, although from 20 to 70% is usually preferred.
  • the solid compositions may be in the form of granules, or dusting powders wherein the active ingredient is mixed with a finely divided solid diluent, e.g. kaolin, bentonite, kieselguhr, dolomite, calcium carbonate, talc, powdered magnesia, Fuller's earth and gypsum. They may also be in the form of dispersible powders or grains, comprising a wetting agent to facilitate the dispersion of the powder or grains in liquid. Solid compositions in the form of a powder may be applied as foliar dusts.
  • a finely divided solid diluent e.g. kaolin, bentonite, kieselguhr, dolomite, calcium carbonate, talc, powdered magnesia, Fuller's earth and gypsum.
  • a finely divided solid diluent e.g. kaolin, bentonite, kieselguhr, dolomite
  • Liquid compositions may comprise a solution or dispersion of an active ingredient in water optionally containing a surface-active agent, or may comprise a solution or dispersion of an active ingredient in a
  • Surface-active agents may be of the cationic, anionic, or non-ionic type or mixtures thereof.
  • the cationic agents are, for example, quaternary ammonium compounds (e.g. cetyltrimethylammonium bromide).
  • Suitable anionic agents are soaps; salts of aliphatic mono ester of sulphuric acid, for example sodium lauryl sulphate; and salts of sulphonated aromatic
  • sodium dodecylbenzenesulphonate sodium, calcium, and ammonium lignosulphonate, butylnaphthalene sulphonate, and a mixture of the sodium salts of diisopropyl and triisopropylnaphthalenesulphonic acid.
  • Suitable non-ionic agents are the condensation products of ethylene oxide with fatty alcohols such as oleyl alcohol and cetyl alcohol, or with alkylphenols such as octyl- or nonyl- phenol (e.g. Agral 90) or
  • non-ionic agents are the partial esters derived from long chain fatty acids and hexitol anhydrides, for example sorbitan monolaurate; the condensation products of the partial ester with ethylene oxide; the lecithins; and silicone surface active agents (water soluble surface active agents having a skeleton which comprises a siloxane chain e.g. Silwet L77).
  • a suitable mixture in mineral oil is Atplus 411F.
  • aqueous solutions or dispersions may be prepared by dissolving the active ingredient in water or an organic solvent optionally containing wetting or dispersing agent(s) and then, when organic solvents are used, adding the mixture so obtained to water optionally containing wetting or dispersing agent(s).
  • organic solvents include, for example, ethylene di-chloride, isopropyl alcohol, propylene glycol, diacetone alcohol, toluene, kerosene, methylnaphthalene, the xylenes and
  • dispersions are generally supplied in the form of a concentrate containing a high proportion of the active ingredient, and the concentrate is then diluted with water before use.
  • the concentrates are usually required to withstand storage for prolonged periods and after such storage, to be capable of dilution with water to form aqueous preparations which remain homogeneous for a sufficient time to enable them to be applied by
  • preparations ready for use may contain varying amounts of the active ingredient(s) depending upon the intended purpose; amounts of 0.01% to 10.0% and preferably 0.1% to 2%, by weight of active ingredient(s) are normally used.
  • a preferred form of concentrated composition comprises the active ingredient which has been finely divided and which has been dispersed in water in the presence of a surface-active agent and a suspending agent.
  • Suitable suspending agents are hydrophilic colloids and include, for example, polyvinylpyrrolidone and sodium carboxymethylcellulose, and the vegetable gums, for example gum acacia and gum tragacanth.
  • Preferred suspending agents are those which impart thixotropic properties to, and increase the viscosity of the concentrate. Examples of preferred
  • suspending agents include hydrated colloidal mineral silicates, such as montmorillonite, beidellite, nontronite, hectorite, saponite, and
  • suspending agents include cellulose derivatives and polyvinyl alcohol.
  • the rate of application of the compounds of the invention will depend on a number of factors including, for example, the compound chosen for use, the identity of the plants whose growth is to be inhibited, the
  • formulations selected for use and whether the compound is to be applied for foliage or root uptak. As a general guide, however, an application rate of from 0.0001 to 20 kilograms per hectare is suitable while from 0.001 to 10, for example 0.001 to 2 kilograms per hectare may be preferred.
  • compositions of the invention may comprise, in addition to one or more compounds of the invention, one or more compounds not of the invention but which possess biological activity. Accordingly in yet a still further embodiment the invention provides a herbicidal composition comprising a mixture of at least one herbicidal compound of formula (I) (IA) or (IB) as hereinbefore defined with at least one other herbicide.
  • the other herbicide may be any herbicide not having the formula (I) (IA) or (IB). It will generally be a herbicide having a complementary action in the particular application.
  • Examples of useful complementary herbicides include:
  • B. hormone herbicides particularly the phenoxy alkanoic acids such as MCPA, MCPA-thioethyl, dichlorprop, 2,4,5-T, MCPB, 2,4-D, 2,4-DB, mecoprop, trichlopyr, clopyralid, and their derivatives (eg. salts, esters and amides);
  • D Dinitrophenols and their derivatives (eg. acetates) such as dinoterb, dinoseb and its ester, dinoseb acetate;
  • dinitroaniline herbicides such as dinitramine, trifluralin,
  • arylurea herbicides such as diuron**, flumeturon, metoxuron, neburon, isoproturon**, chlorotoluron**, chloroxuron, linuron, monolinuron, chlorobromuron, daimuron, methabenzthiazuron;
  • uracil herbicides such as lenacil**, bromacil and terbacil;
  • K. phosphorothioate herbicides such as piperophos, bensulide, and
  • L. thiocarbamate herbicides such as cycloate, vernolate, molinate,
  • N. benzoic acid herbicides such as 2,3,6-TBA, dicamba and chloramben;
  • O. anilide herbicides such as pretilachlor, butachlor, alachlor,
  • P. dihalobenzonitrile herbicides such as dichlobenil, bromoxynil** and ioxynil
  • Q. haloalkanoic herbicides such as dalapon, TCA and salts thereof
  • diphenylether herbicides such as lactofen, fluroglycofen or salts or ester thereof, nitrofen, bifenox, aciflurofen and salts and esters thereof, oxyfluorfen, fomesafen, chlornitrofen and chlomethoxyfen;
  • metsulfuron and esters thereof metsulfuron and esters thereof; benzsulfuron and esters thereof such as DPX-M6313, chlorimuron and esters such as the ethyl ester thereof pirimisulfuron and esters such as the methyl ester thereof,
  • V. imidazolidinone herbicides such as imazaquin, imazamethabenz, imazapyr and isopropylammonium salts thereof, imazethapyr;
  • Y. organoarsenical herbicides such as monosodium methanearsonate (MSMA); Z. herbicidal amide derivative such as napropamide, propyzamide,
  • AA triketones such as sulcotrione
  • miscellaneous herbicides including ethofumesate, cinmethylin,
  • difenzoquat and salts thereof such as the methyl sulphate salt, clomazone, oxadiazon, bromofenoxim, barban, tridiphane,
  • Examples of useful contact herbicides include:
  • bipyridylium herbicides such as those in which the active entity is paraquat and those in which the active entity is diquat;
  • This Example illustrates the preparation of cyanomethyl monate A (Compound No 9 of Table 1).
  • This Example illustrates the preparation of 3-bromobenzyl monate A (Compound No 11 of Table 1).
  • This Example illustrates the preparation of 3-methylbenzyl monate A (Compound No 12 of Table 1).
  • This Example illustrates the preparation of 4-hydroxymethylbenzyl monate A (Compound No 13 of Table 1).
  • N-bromosuccinimide (17.8g, 100mmol), benzoyl peroxide (100mg) and carbon tetrachloride (50ml) and refluxed for 21 ⁇ 2 hours.
  • the reaction was then filtered, and the filtrate evaporated in vacuo.
  • methyl-4-bromomethylbenzoate (9.2g, 40mmol) in toluene (80ml) was cooled to -30°C and a solution of diisobutyl aluminium hydride in toluene (60ml, 25%, 80mmol) was added dropwise and stirred for 1 hour.
  • the solution was allowed to warm to room temperature and stirred a further 2 hours.
  • the reaction was then quenched with methanol, filtered, and the filtrate washed with aqueous sodium bicarbonate solution and then brine.
  • the orgnaic layer was dried (MgSO 4 ) and evaporated in vacuo to yield
  • This Example illustrates the preparation of 4-dimethylaminobenzoyl-monhydrazide A (Compound No 16 of Table 1).
  • This Example illustates the preparation of 1-bromo-8-octyl monate A (Compound No 17 of Table 1).
  • the Example illustrates the preparation of cetyl monate A (Compound No 20 of Table 1).
  • N,N-dimethylpropyleneurea (0.38ml) at room temperature for 4 hours and then at 70°C for 2 hours. Volatile components were removed by evaporation in vacuo. Separation on silica eluting with 55:45 acetone/hexane gave the desired product as a colourless syrup.
  • Decyl monate A (Compound No 73 of Table I)
  • N,N-dimethylpropyleneurea (0.476g) and sodium iodide (166mg, 1.11mM) at room temperature for 1.5 hours and then left to stand for 4 days. Volatile components were removed by evaporation in vacuo. Separation on silica eluting with 55:45 acetone/hexane gave the desired product as a colourless syrup.
  • Ethyl propion-2-yl monate A (Compound No 45 of Table I), obtained as a mixture of diastereoisomers.
  • Ethoxymethyl monate A (Compound No 76 of Table 1).
  • Monic acid A 200mg, 0.58mM was dissolved in tetrahydrofuran (5ml) and cooled to -10°C under nitrogen. Triethylamine (59mg, 0.58mM) and isobutylchloroformate (80mg, 0.58mM) were added and stirred for 30 minutes. A solution of diethylamine (47mg, 0.58mM) in tetrahydrofuran (0.5 ml) was added an the reaction mixture stirred for 1 hour and then at room
  • N-(2-Ethoxyethyl)monicamide A (Compound No 78 of Table 1).
  • N,N-bisallylmonicamide A (Compound No 79 of Table 1).
  • N,N-Dimethylmonichydrazide A (Compound No 82 of Table 1).
  • N-Allylmonicamide A (Compound No 86 of Table 1).
  • N,N-bis(2-hydroxyethyl)monicamide A (Compound No 87 of Table 1).
  • Phenyl monate A (Compound No 50 of Table 1)
  • Neopentyl monate A (Compound No 38 of Table 1)
  • Trimethylsulphonium iodide (59mg, 0.29mM) was dissolved in water (5ml) and treated with Dowex 1 ⁇ 2 (HO-) resin for 10 minutes. The solution was filtered into a solution of monic acid A (100mg, 0.29 mM) in water (10ml). The solution was freeze-dried to give the desired product.
  • Pseudomonic acid A 200mg, 0.40mM was dissolved in acetone (2ml) and stirred with 1-chloro-2vinyloxyethane (85mg, 0.60mM) and sodium iodide (132mg, 88mM). Potassium carbonate (83mg, 0.60mM) was added and the mixture stirred at room temperature for 2 hours and at reflux overnight. Volatile components were removed by evaporation in vacuo. The residue was taken up in dimethylformamide (1ml) and N,N-dimethylpropyleneurea
  • Ethyl pseudomonate A (Compound No 90 of Table 1).
  • Pseudomonic acid A 200mg, 0.40mM was dissolved in tetrahydrofuran (4ml) and cooled to -10°C under nitrogen. Triethylamine (41mg, 0.40mM) and isobutylchloroformate (55mg, 0.40mM) were added and stirred for 30 minutes. A solution of diethylamine (32mg, 0.40mM) in tetrahydrofuran (2ml) was added an the reaction mixture stirred for 30 minutes and then stood at room temperature overnight. The reaction mixture was filtered and evaporated in vacuo. The residue was taken up in water (10ml) and extracted with chloroform (3x10ml).
  • Monic acid A 50mg, 0.15mM was dissolved in tetrahydrofuran (2ml) and was treated with isopropylamine (8.6mg, 0.15mM). After 20 minutes at room temperature, a precipitate formed which was collected by filtration to give the desired product.
  • Pseudomonic acid A triethylamine salt (Compound No 98 of Table 2)
  • Monic acid A (1.2g, 3.48mM) was suspended in water (35ml) and was treated with an aqueous 0.1M solution of sodium hydroxide (34.8ml, 3.48mM). The solution was freeze dried to give the desired product as a white solid.
  • N-Methoxymonicamide A (Compound No 106 of Table 1)
  • This Example illustrates the herbicidal properties of compounds according to the invention.
  • Tween 20 is a Trade Mark for a surface-active agent comprising a condensate of 20 molar proportions of ethylene oxide with sorbitan laurate.
  • Span 80 is a Trade Mark for a surface-active agent comprising sorbitan mono-laurate.
  • the volume was made up to 5cm 3 with water, glass beads were added and this mixture was then shaken to effect dissolution or suspension of the chemical, after which the beads were removed. In all cases, the mixture was then diluted with water to the required spray volume. If sprayed independently, volumes of 25cm 3 and 30cm3 were required for pre-emergence and post-emergence tests respectively; if sprayed together, 45cm 3 was required.
  • the sprayed aqueous emulsion contained 4% of the initial solvent/surfactant mix and the test chemical at an appropriate concentration.
  • the spray compositions so prepared were sprayed onto young pot plants (post-emergence test) at a spray volume equivalent to 1000 litres per hectare for Compound Numbers 1 to 22 and 400 litres per hectare for

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

A herbicidal composition comprises ester, amide, aryl and heterocyclic derivatives of monic acid A, monic acid B, monic acid C, monic acid ketone and pseudomonic acid. Novel monic acid esters may be represented by the formula (mon)-CO-XR3 wherein (mon) is a residue of a monic acid compound, (mon)-COOH, X is O or S and R3 is an alkyl group substituted by a group -A-R11 wherein A is O or a group S(O)¿x?, and R?11¿ is an optionally substituted alkyl, alkenyl, alkynyl, phenyl, alkyl carbonyl, cycloalkyl or heterocyclyl group.

Description

HERBICIDES
This invention relates to chemical compounds useful as herbicides, to processes for preparing them and to herbicidal compositions and processes utilising them.
A number of derivatives of monic acid are known to have utility as biologically active compounds for use in human and veterinary medicine. Such compounds are described inter alia in GB 1587058.
We have now found that certain monic acid derivatives, including esters, amides and salts have a novel and unexpected herbicidal activity.
According to the present invention there is provided a herbicidal composition comprising a compound of the formula (I) or (IA) or (IB) in admixture with a herbicidally acceptable carrier or diluent, wherein Y represents (IC) or (ID) or (IE) and wherein R2 is a group CO-XR3 wherein X is O or S and R3 is hydrogen or an agrochemically acceptable ester-forming radical; or R2 is a group -R4 wherein R4 is an optionally substituted aryl or heterocyclic group; or R2 is a group CO-NR5R6 wherein R5 and R6 are the same or different and each represent an agrochemically acceptable
amide-forming radical; stereoisomers of the compounds of formula (I), (IA) and (IB) and salts of the compound of formula (I), (IA) and (IB) wherein R2 is COXR3, X is 0 and R3 is hydrogen.
According to a further aspect of the present invention there is provided a process of severely damaging or killing unwanted plants, which comprises applying to the plants, or to the growth medium of the plants, a herbicidally effective amount of a compound of the formula (I) or (IA) wherein Y represents (IC) or (ID) or (IE);
R2 is a group CO-XR3 wherein X is 0 or S and R3 is hydrogen or an
agrochemically acceptable ester-forming radical; or
R2 is a group -R4 wherein R4 is an optionally substituted heterocyclic group; or R2 is a group -CO-NH-CH2-CO-W wherein W is hydrogen, optionally substituted phenyl, optionally substituted C1 to C20 alkyl, optionally substituted C2 to C8 alkenyl, optionally substituted C2 to C8 alkynyl, optionally substituted heterocyclyl or C3 to C7 cycloalkyl; or
R2 is a group -CO-NH-NH2 or -CO-NH-NH-CO-Y wherein Y is optionally substituted C1 to C20 alkyl, optionally substituted C2 to C8 alkenyl, optionally substituted aryl, optionally substituted aralkyl or optionally substituted heterocyclyl; or
R2 is a group CO-NR5'R6' wherein R5' and R6' are the same or different and each represent (a) hydrogen, or (b) C1-20 alkyl, C2-8 alkenyl, either of which may be optionally substituted with C3-7 cycloalkyl, halogen, carboxy, C1-6 alkoxycarbonyl, carbamyl, aryl, heterocyclyl, hydroxy, C1-6
alkanoyloxy, amino, mono- or di-(C1-6)alkylamino; or (c) C3-7 cycloalkyl optionally substituted with C1-6 alkyl; or
(d) optionally substituted aryl; or
(e) optionally substituted heterocyclyl; or
(f) R5' and R6' together with the nitrogen atom to which they are attached represent an optionally substituted C5-7 heterocyclic ring; or
R2 is a group -CO-O-R7 wherein R7 is a C3-20 alkyl, C3-8 cycloalkyl, C4-20 alkenyl, aralkyl, cycloalkylalkyl, heterocyclyl or heterocyclylalkyl group which group is substituted with a ketonic oxo group; or R7 is a group -CH2-COR13 wherein R13 is acyl, aralkyl, amino, ureido or carbamic acid ester residue,
and stereoisomers of the compound of formula (I) and salts of the compound of formula (I) wherein X is 0 and R3 is hydrogen.
The term "aryl" as used herein includes phenyl, and naphthyl
optionally substituted with up to five substituents which may be
independently selected from halogen, C1-6alkyl, C1-6alkoxy, C1-6thioalkyl, halo(C1-6)alkyl, hydroxy(C1-6)alkyl, halo(C1-6)alkoxy, C2-8 alkenyl, C2-8 alkeneoxy, C2-8 thioalkenyl, C2-8 alkynyl, C2-8 alkyneoxy, C2-8
thioalkynyl, hydroxy, cyano, nitro, amino, mono- and di- C1-6 alkylamino, C1-6 alkanesulphinyl, C1-6 alkane sulphonyl, carboxy, C1-6alkoxycarbonyl, and C1-6alkoxycarbonyl(C1-6)alkyl groups.
The term "aralkyl" as used herein includes groups in which the aryl moiety is a phenyl group which may be optionally substituted as
hereinbefore defined for aryl and in which the alkylene radical has from 1 to 4 carbon atoms.
The term "heterocyclyl" as used herein includes aliphatic or aromatic single or fused rings comprising up to four hetero atoms in the ring selected from oxygen, nitrogen and sulphur and optionally substituted with aryl, with another heterocyclic ring or with one or more of those
substituents mentioned above as optional substituents for aryl.
When R2 is a group CO-XR3, X is preferably 0.
Suitable ester-forming radicals, R3, include optionally substituted C1 to C20 alkyl, optionally substituted C2 to C20, for example C2 to C8 alkenyl, optionally substituted C2 to C20, for example C2 to C8 alkynyl, optionally substituted C3 to C7 cycloalkyl, optionally substituted aryl or optionally substituted heterocyclyl.
Optional substituents which may be present in optionally substituted alkyl, alkenyl or alkynyl groups, such as those represented by R3, include
C3-7 cycloalkyl, C1-10 alkoxy, C1-10 thioalkyl, C2-8 alkenoxy, C2-8 thioalkenyl, C2-8 alkyneoxy, C2-8 thioalkynyl, halogen, halo-C1-10 alkoxy, halo-C2-8alkeneoxy, halo-C2-8alkynoxy, carboxy, C1-6alkoxycarbonyl, carbamoyl, aryl, heterocyclyl, hydroxy, cyano, nitro, C1-6alkanoyloxy, amino, mono- and di-(C1-6)alkylamino.
Optional substituents which may be present in C3-7cycloalkyl groups, such as those represented by R3, include C1-6alkyl halo-C1-6alkyl and those substituents listed above in relation to alkyl, alkenyl and alkynyl groups.
When R3 is alkyl, optionally substituted by aryl it may be regarded as an aralkyl group as defined above.
Suitable ester-forming radicals R3 also include C1 to C10 alkyl optionally substituted by hydroxy, halogen, cyano. Suitable ester-forming radicals R3 also include C2 to C10, for example C2 to C4 alkenyl, for example vinyl, prop-2-ene-1-yl, and but-1-ene-4-yl which may be
unsubstituted or optionally substituted by hydroxy (except in the case of vinyl), by halogen or by cyano.
A further preferred group R3 is a C1-10 alkyl group, and preferably a C1-4 alkyl group, substituted by a group -A-R11 wherein A is 0 or a group S(O)x wherein x is 0, 1 or 2 and R11 is an optionally substituted C1 to
C10, and preferably optionally substituted C1-6, for example C1 to C4 alkyl group, an optionally substituted C2 to C8, and preferably optionally substitued C2-6, for example C2 to C4 alkenyl group, an optionally
substitued C2 to C8, and preferably optionally substitued C2-6, for example
C2 to C4 alkynyl group or an optionally substituted phenyl group, an optionally substituted C1-6 alkyl carbonyl group or an optionally
substituted C3-7 cycloalkyl group, for example an optionally substituted C3-6 cycloalkyl group, or an optionally substitututed C3-7 heterocyclic group, for example an optionally substituted aliphatic heterocyclic group, for example an optionally substituted oxygen-containing aliphatic
heterocyclic group. An example of a group R3 having this substitution is the group -(CH2)n,-A-CH=CH-R12 wherein n' is an integer from 1 to 4 and R12 is hydrogen or a C4 to C4 alkyl group. A is preferably oxygen.
Optional substituents may be those indicated above for alkyl, alkenyl, alkynyl and aryl respectively. Unless otherwise specified, alkyl, alkenyl and alkynyl groups, incluαddiinngg ffoorr example those present in R3, may be straight or branched chain groups.
Salts of the compound of formula (I) (IA) and (IB) wherein R2 is the group CO-XR3 and in which X is 0 and R3 is hydrogen include for example metal salts, e.g. aluminium, alkali metal salts, such as sodium or
potassium, alkaline earth metal salts, such as calcium or magnesium, and ammonium or substituted ammonium salts for example those with lower alkyl-amino such as triethylamine, hydroxy-lower alkylamines such as
2-hydroxyethylamine, bis(2-hydroxyethyl)-amine, or
tri-(2-hydroxyethyl)-amine, cycloalkylamines such as bicyclohexyl-amine, or with procaine, dibenzylamine, N,N-dibenzyl-ethylenediamine,
N-ethylpiperidine, N-benzyl-β-phenethyl-amine, dehydroabietylamine,
N,N'-bis-dehydroabietylethylenediamine, or bases of the pyridine type (such as pyridine, collidine, or quinoline) or trimethylsulphonium.
When R2 is an optionally substituted heterocyclic group -R4, preferred heterocyclic groups R4 include groups of formula (II) wherein R14 and R15, which may be the same or different, are independently selected from hydrogen, optionally substituted phenyl, optionally substituted C1 to C20 alkyl, optionally substituted C2 to C8 alkenyl, optionally substituted C2 to C8 alkynyl, optionally substituted heterocyclyl or C3 to C7 cycloalkyl or from those general substituents for heterocyclyl listed above, X is a divalent group, -Y'-C=C- and Y' is oxygen or sulphur.
Preferably R4 is an optionally substituted heterocyclic ring of formula (III) wherein Y is 0 or S and R14 and R15 have the meanings given previously. An especially preferred group R is an optionally substituted oxazol-2-yl group, for example a group of formula (IV) wherein R14 has the meaning given previously.
Alternatively R4 may be a group of formula (IV) wherein R14 is itself an optionally substituted heterocyclic group, for example a group of the formula (IVa), (IVb) or (IVc) in which formulae R16, R17, and R18 may be the same or different each is selected from hydrogen, halogen, optionally substituted (C1-6)alkyl, aryl, aralkyl, heterocyclyl, (C1-6)alkoxy, hydroxy, carboxy and salts thereof, (C1-6)alkoxycarbonyl, carbamoyl, mono- or di-(C1-6)alkylcarbamoyl, sulphamoyl, mono- and di-(C1-6)alkylsulphamoyl, cyano, nitro, amino, mono-and di-(C1-6)alkylamino, acylamino, ureido,
(C1-6)-alkoxycarbonylamino, (C1-6)alkoxyimino,
2,2,2-trichloroethoxycarbonylamino, acyl, (C1-6)alkylthio, arylthio, (C1-6)alkanesulphinyl, arysulphinyl, (C1-6)alkanesulphonyl and
arylsulphony1.
Suitably, R14 is a group of formula (IVc) and R16, R17 and R18 are preferably hydrogen.
A further suitable ester-forming radical R3 is a group R7 wherein R7 represents an optionally substituted C3-20 alkyl, for example C3-10 alkyl, C3-8 cycloalkyl, C3-20 alkenyl, aralkyl, cycloalkylalkyl, heterocyclyl or heterocyclylalkyl group which group is additionally substituted with a ketonic oxo group.
Thus one sub class of the group R2 when it is a group -CO-OR7 is a group of formula (V) wherein Z is an optionally substituted C1 to C12 alkylene group (-(CH2)n,,- wherein n" is from 1 to 12) and R8 represents a
C1-10 alkyl, C3-8 cycloalkyl, C2-10 alkenyl, C2-10 alkynyl, aryl, aralkyl, cycloalkylalkyl or heterocyclyl group, each of which may be optionally substituted. Optional substituents may be those specified above for the groups alkyl, cycloalkyl, alkenyl, aryl and heterocyclyl respectively.
A further sub-class of the group R2 is a group CO-OR7 and R7 is a group -CH2-CO-R13 wherein R13 is suitably a carbamic acid ester residue.
By the term "carbamic acid ester residue" is meant a group of general formula -N(R19)-CO-NR20R21 wherein R19 is hydrogen or an optionally substitued C1-6 alkyl group and R20 and R21 are independently selected from hydrogen or any of the groups R5 and R6 given below.
As examples of suitable agrochemically acceptable amide-forming radicals R5 and R6, which may be the same or different, there may be mentioned:
(a) hydrogen or
(b) an optionally substituted C1-20 alkyl group, an optionally
substituted C2-20, for example C2-8 alkenyl group or an optionally substituted C2-20, for example C2-8 alkynyl group or
(c) optionally substituted C3 to C7 cycloalkyl or
(d) optionally substituted aryl or
(e) optionally substituted heterocyclyl; or
(f) R5 and R6 together with the nitrogen atom to which they are
attached represent an optionally substituted C5-7 heterocyclic ring or
(g) R5 is hydrogen and R6 is a group -NR22-N23R24 wherein R22 is hydrogen or C1-6 alkyl are R23 and R24, which may be the same or different, may independently take any of the meanings given for R5 and R6 under (a), (b), (c), (d), (e) and (f) above or
(h) R6 is a group -NR22-N=CR23R24 wherein R22, R23 and R24 have
the meanings given previously or
(i) R5 is hydrogen and R6 is a group -CR25R26-CO-W or - NR27-CO-W wherein W is optionally substituted phenyl or optionally substituted heterocyclyl, R25, R26 and R27 are indendently hydrogen or optionally substitued C1-6 alkyl groups.
Preferred agrochemically acceptable amide-forming groups R5 and R6 are those wherein R5 is hydrogen or a C1-4 alkyl group and R6 is a C1-4 alkyl group, each of which alkyl groups may independently be optionally
substituted by C3-7 cycloalkyl, C1-4 alkoxy, halogen, carboxy, C1-6 alkoxycarbonyl, carbamyl, optionally substituted aryl, optionally
substituted heterocyclyl, hydroxy, C1-6 alkanoyloxy, amino, mono- or di-(C1-6)alkylamino or wherein R5 and R6 together with the nitrogen atom to which they are attached represent an optionally substituted C5-6 aliphatic heterocyclic ring. As examples of suitable groups wherein R5 and R6 together with the nitrogen atom to which they are attached form an
optionally substituted C5-6 heterocyclic ring, there may be mentioned morpholinyl, piperidyl, piperazinyl, or pyrollidinyl, each of which may be optionally substituted by halogen or C1-4 alkyl.
When R5 is hydrogen and R6 is a group -CR25R26-CO-W or - NR27-CO-W, R25, R26 and R27 are preferably hydrogen and W is preferably optionally substituted phenyl or an optionally substituted 5 or 6-membered
heterocyclic ring containing from 1 to 3 heteroatoms selected from oxygen, nitrogen and sulphur, for instance thienyl or furanyl.
Suitable substituents for W when it is a phenyl or heterocyclyl group include those mentioned previously and especially halogen, C1 to C6 alkyl, C1 to C6 alkoxy, hydroxy, carboxy, C1-C6 alkoxycarbonyl, carbamoyl, mono-or di- (C1 to C6) alkyl carbamoyl, sulphamoyl, mono- and di-(C1 to C6) sulphamoyl, cyano, for example m- or p- cyano, nitro, amino, mono- and di- (C1 to C6) alkylamino, C1 to C6 acylamino, ureido, C1 to C6
alkoxycarbonylamino, 2,2,2-trichloroethoxycarbonylamino, C1 to C6 alkanoyl, C1 to C6 alkylthio, C1 to C6 alkanesulphinyl, and C1 to C6 alkanesulphonyl.
Certain compounds of formula (I), (IA) or (IB) are novel.
According to a further aspect of the present invention there is provided a compound of the formula (I) or (IA) or (IB) above wherein R2 is a group CO-XR3 X, is 0 or S and R3 is a C1-10 alkyl group substituted by a group -A-R11 wherein A is 0 or a group S(0)x wherein x is 0, 1 or 2 and R11 is an optionally substituted C1 to C10 akyl group, an optionally
substituted C2 to C8 alkenyl group, an optionally substitued C2 to C8 alkynyl group, an optionally substituted phenyl group, an optionally substituted C1-6 alkyl carbonyl group, optionally substituted C3-7
cycloalkyl group or an optionally substituted C3-7 heterocyclic group provided that R3 is not a group -(CH2)2- when R11 is ethyl.
Optional substituents may be those indicated previously as suitable for alkyl, alkenyl, alkynyl, phenyl, cycloalkyl or heterocyclyl
retrospectively.
Preferably, R3 is a C1-4 alkyl group substituted by a group -A-R11 wherein A is 0 or a group S(0)x wherein x is 0, 1 or 2 and R11 is an optionally substituted C1 to C6 akyl group, an optionally substituted C2 to
C6 alkenyl group, an optionally substitued C2 to C6 alkynyl group, an optionally substituted phenyl group, or an optionally substituted C1-6 alkyl carbonyl group, an optionally substitued C3-6 cycloalkyl group or an optionally substituted aliphatic C3-7 oxygen-containing heterocyclic group, provided that R3 is not a group -(CH2)2- when R11 is ethyl.
In one embodiment of the present invention, R3 is the group
-(CH2)n,-A-CH=CH-R wherein n' is an integer from 1 to 4 A is 0 or a group S(0) wherein x is 0, 1 or 2 and R12 is hydrogen or a C1 to C4 alkyl group.
Compounds of formula (I) wherein R2 is the group COOH and wherein Y represents (IC) or (ID) or (IE) are disclosed in West German
Offenlegungsschriften No. 2726619, 2726618 and 2848687 and European Patent
Application No 79300371.6. Such compounds having the tri-substituted double bond in the E-configuration are referred to as monic acid C, monic acid A and monic acid B respectively. Preferably the compounds of the present invention are derivatives of Monic acid A. However, the compounds of the present invention may exist in the E (natural) and Z (or iso) geometrical forms in respect of the tri-substituted double bond. The stereochemistry of the compound of formula (I) is thus preferably defined such that the moiety (VI) is that moiety having the trivial name "normonyl"
(3-[(2S,3R,4R,5S)-5-{(2S,3S,4S,5S)-2,3-epoxy-5-hydroxy-4-methylhexyl}¬
-3,4-dihydroxytetrahydropyran-2-yl]-2-methyl-1(E)-enyl radical) such that when R2 is the group -COOH, the compound of formula (I) is monic acid A.
Compounds of formula (I) may thus conveniently be named as (1-normonyl) derivatives and esters of monic acid A are conveniently named as monate A esters. It will be appreciated that in compounds of formula (I), the group R2 may contain one or more chiral centres. The present invention
encompasses all such resultant isomeric possibilities.
Particular examples of compounds for use in the composition of the invention are illustrated in Table 1 below wherein the compound is of formula (I) and the stereochemistry of the moiety (VI) is that of the
"normonyl" radical as described above. Table 2 lists examples of compounds for use in the composition of the present invention wherein the compound is of formula (IB), being derivatives of pseudomonic acid. Table 3 lists examples of compound for use in the composition of the present invention wherein the compound is of formula (I) and Y is of formula (IC), being derivatives of monic acid C.
It will be readily appreciated that compounds having values of R2 corresponding to those listed in Table 1 may be prepared wherein the compound is of formula (I) and Y is of the formula (IC) (being derivatives of monic acid C) and wherein the compound is of formula (IB) (being derivatives on pseudomonic acid) and such compounds should be considered as being specifically disclosed herein. Corresponding derivatives of the compounds of formula (IA) and of formula (I) wherein Y is of formula (ID) and (IE) may also be readily prepared and should similarly be considered as being specifically disclosed herein.
Figure imgf000010_0001
Figure imgf000011_0001
Figure imgf000012_0001
Figure imgf000013_0001
TABLE 2
(Pseudomonic acid deriatives)
COMPOUND R2
NUMBER
89 -CO-O-CH2-CH2-O-CH=CH2
90 -CO-O-C2H5
91 -CO-O-(CH2)2-OH
92 -CO-N(C2H5)2
98 -CO-O- +NH-(C2H5)3
TABLE 3
(monic acid C deriatives)
COMPOUND R2
NUMBER
107 -CO-OH
108 -CO-O-CH2-CH2-O-C2H5
Compounds for use in the present invention are either known compounds or may be prepared by methods analogous to those used for the preparation of corresponding known compounds.
The compounds may be regarded as derivatives of monic acid which may be prepared by the selective hydrolysis of pseudomonic acid. A further useful starting material is the ketone which may be obtained from
pseudomonic acid by ozonolysis at -50 to -80°C as described for example in GB 1587 060. Derivatives of pseudomonic acid may of course be prepared directly for pseudomonic acid as starting material.
In general it is desirable to protect the hydroxy groups during reactions of the the starting material such as monic acid or derivatives thereof or the corresponding ketone. A wide variety of suitable protecting groups is known and examples, are described for example in EP 0399 645. Particularly suitable protecting groups are silyl groups since these are readily removed under mild conditions. Such groups are introduced by conventional silylating agents, including halosilanes and silazanes. The hydroxyl-protecting groups may subsequently be removed by methods known in the art, including enzymatic methods. For example silyl protecting groups may generally be removed by mild acid hydrolysis followed by alkaline hydrolysis as described for example by J P Clayton, K Luk and N H Rogers in
Chemistry of Pseuodomonic acid, Part II J.C.S. Perkin Trans I, 1979, 308.
The compound No 1 of Table 1 is a known compound and may be prepared for example as described above. A more detailed preparation is given in
Examples 2, 3, 4 and 6 of GB 1,587,058. Salts of the compound of formula (I) wherein X is 0 and R3 is hydrogen (i.e. salts of Compound No 1 of
Table 1) may also be prepared from monic acid by routine methods as described for example in GB 1,587,058. Typical processes include the reaction of monic acid with a base, for example a hydroxide, carbonate or bicarbonate of the desired cation followed by the removal of water; ion exchange with an appropriate resin; and reaction with amines.
Compound No 2 and Compound No 21 of Table 1 are known compounds and may be prepared for example as described in Examples 24 and 3 respectively of GB 1,587,059. General methods of preparing compounds of formula (I) wherein R2 is a group -COXR3 and X is 0 and R3 is an agrochemically acceptable ester-forming radical are also disclosed in GB 1,587,059.
Compound No 3 of Table 1 is a known compound and may be prepared for example using the general methods described in GB 1,587,059 or as more specifically described in J Antibiot. 198841(5).
Compound No 4 of Table 1 is a known compound and may be prepared for example using the methods disclosed in EP 0002 371 as more specifically disclosed in Example 5 thereof. Compounds wherein R2 in the compound of formula (I) is -CO-XR3 and X is S may similarly be prepared using the general methods disclosed in EP 0002 371.
Compound Nos 6 and 7 of Table 1 are known compounds and may be prepared for example as described in EP 0025 288 and as more specifically described in Examples 2 and 5 thereof. Compounds wherein R2 in the compound of formula (I) is a group of formula -CO-O-R7 and R7 is a C3-20 alkyl, C3-8 cycloalkyl, C4-20 alkenyl, aralkyl, cycloalkylalkyl,
heterocyclyl or heterocyclylalkyl group which group is substituted with a ketonic oxo group, may be prepared using the general methods described in
EP 0025 288.
Compound No 8 of Table 1 is a known compound and may be prepared for example using the methods disclosed in Japanese patent No 54-151132. Compound No 10 of Table 1 is a known compound and may be prepared for example using the methods disclosed in EP 0052437, and as more
specifically described in Example 2 thereof. Compounds of formula (I) wherein R2 is a group -CO-OR3 may also be prepared as described in Japanese
Patent No 54-12376 or EP 0052437.
Compound No 14 of Table 1 is a known compound and may be prepared for example using the methods disclosed in EP 0087 953, and as more
specifically described in Example 21 thereof. Compounds of formula (I) wherein R2 is a group -CO-NH-CH2-CO-W as hereinbefore defined may be prepared using the general methods set out in EP 0087 953 where it is an intermediate in the manufacture of the compounds wherein R2 is a
heterocyclic group -R4 having the formula (III) above which may similarly be prepared as described in EP 0087 953. Thus for example, Compound No 19 may be prepared using an analogous method to that described in Example 14 of EP 0087 953 (5-methyl-2-(1-normon-2-yl)oxazole or as more specifically described in J Chem Soc, Perkin Trans. I 1989 (11) 2059-63. Similarly,
Compound No 22 of Table 1 may be prepared as described in Example 10 of
EP 0087 953.
Compound No 15 of Table 1 is a known compound and may be prepared for example using the methods disclosed in EP 0123378, and as more
specifically disclosed in Example 8 thereof. Compounds of general formula (I) wherein R2 is a group -CO-NH-NH2 or -CO-NH-NH-CO-W as hereinbefore defined may be prepared using the general methods described in EP 0 123 378 where such compounds are intermediates to heterocyclic derivatives which themselves provide further examples of compounds of the general formula (I) wherein R2 is a group -R4.
Compound No 18 of Table 1 is a known compound and may be prepared for example using the methods disclosed in EP 0399 645, and as more
specifically disclosed in Example 16 thereof. Compounds of general formula
(I) wherein R2 is a group -R4 having the formula (II) above may be prepared using the general methods of EP 0399 645.
Compound of formula (I), (IA) or (IB) wherein R2 is a group of formula
-CONR5R6 may be prepared using the general methods described in
EP 0001914.
In general therefore, typical processes for the manufacture of compounds of formula (I), (IA) or (IB) wherein R2 is the group -COOR3 include the reaction of a salt of monic acid (A, B or C) or pseudomonic acid, for example an alkali metal salt, with a compound R3-L wherein L is a leaving group such as halogen or mesolate to form an ester. The reaction suitably takes place in a solvent such as dimethylformamide or
dimethylsulphoxide at a temperature in the range 10°C to 100°C and optionally in the presence of a co-solvent such as
hexamethylenephosphonamide or N,N-dimethylpropyleneurea and optionally in the presence of a catalyst, such as an iodide catatlyst. If desired the salt of monic acid or pseudomonic acid may be prepared in situ, for example by treatment of the acid with the appropriate base such as the carbonate.
Alternatively, compounds of formula (I), (IA) or (IB) wherein R2 is the group -COXR3 or -CONR5R6 may be prepared by the action of a compound R3XH or R5R6NH on a monic or pseudomonic acid or a simple activated derivative thereof. Suitably the raction takes place in a solvent such as tetrahydrofuran, diethyl ether, dichloromethane or chloroform and at a temperature in the range from -10°C to 70°C.
Other suitable methods of preparation of the compounds for use in the composition of the present invention are described in the literature with specific reference to the patents and papers cited above.
The compounds for use in the compositions of the present invention are active against a broad range of weed species including monocotyledonous and dicotyledonous species. Many compounds show good selectivity in crops, particularly wheat, barley, maize, oil seed rape, sugar beet and rice. The compounds for use in compositions of the present invention are preferably applied directly to unwanted plants (post-emergence application) but they may also be applied to the soil before the unwanted plants emerge
(pre-emergence application).
Thus acording to a further aspect of the present invention there is provided a process of severely damaging or killing unwanted plants, which comprises applying to the plants or the the growth medium of the plants a herbicidally effective amount of a compound of the formula (I) or (IA) or (IB) as hereinbefore defined wherein R2 is as hereinbefore defined.
Novel compounds of the present invention are preferably used in the form of a composition comprising a compound of formula (I) in admixture with a carrier comprising a solid or liquid diluent.
Suitable compositions of the present invention include both dilute compositions, which are ready for immediate use, and concentrated
compositions, which require to be diluted before use, usually with water. Preferably the compositions contain from 0.01% to 90% by weight of the active ingredient. Dilute compositions ready for use preferably contain from 0.01 to 2% of active ingredient, while concentrated compositions may contain from 20 to 90% of active ingredient, although from 20 to 70% is usually preferred.
The solid compositions may be in the form of granules, or dusting powders wherein the active ingredient is mixed with a finely divided solid diluent, e.g. kaolin, bentonite, kieselguhr, dolomite, calcium carbonate, talc, powdered magnesia, Fuller's earth and gypsum. They may also be in the form of dispersible powders or grains, comprising a wetting agent to facilitate the dispersion of the powder or grains in liquid. Solid compositions in the form of a powder may be applied as foliar dusts.
Liquid compositions may comprise a solution or dispersion of an active ingredient in water optionally containing a surface-active agent, or may comprise a solution or dispersion of an active ingredient in a
water-immiscible organic solvent which is dispersed as droplets in water.
Surface-active agents may be of the cationic, anionic, or non-ionic type or mixtures thereof. The cationic agents are, for example, quaternary ammonium compounds (e.g. cetyltrimethylammonium bromide). Suitable anionic agents are soaps; salts of aliphatic mono ester of sulphuric acid, for example sodium lauryl sulphate; and salts of sulphonated aromatic
compounds, for example sodium dodecylbenzenesulphonate, sodium, calcium, and ammonium lignosulphonate, butylnaphthalene sulphonate, and a mixture of the sodium salts of diisopropyl and triisopropylnaphthalenesulphonic acid.
Suitable non-ionic agents are the condensation products of ethylene oxide with fatty alcohols such as oleyl alcohol and cetyl alcohol, or with alkylphenols such as octyl- or nonyl- phenol (e.g. Agral 90) or
octyl-cresol. Other non-ionic agents are the partial esters derived from long chain fatty acids and hexitol anhydrides, for example sorbitan monolaurate; the condensation products of the partial ester with ethylene oxide; the lecithins; and silicone surface active agents (water soluble surface active agents having a skeleton which comprises a siloxane chain e.g. Silwet L77). A suitable mixture in mineral oil is Atplus 411F.
The aqueous solutions or dispersions may be prepared by dissolving the active ingredient in water or an organic solvent optionally containing wetting or dispersing agent(s) and then, when organic solvents are used, adding the mixture so obtained to water optionally containing wetting or dispersing agent(s). Suitable organic solvents include, for example, ethylene di-chloride, isopropyl alcohol, propylene glycol, diacetone alcohol, toluene, kerosene, methylnaphthalene, the xylenes and
trichloroethylene.
The compositions for use in the form of aqueous solutions or
dispersions are generally supplied in the form of a concentrate containing a high proportion of the active ingredient, and the concentrate is then diluted with water before use. The concentrates are usually required to withstand storage for prolonged periods and after such storage, to be capable of dilution with water to form aqueous preparations which remain homogeneous for a sufficient time to enable them to be applied by
conventional spray equipment. Concentrates conveniently contain 20-90%, preferably 20-70%, by weight of the active ingredient(s). Dilute
preparations ready for use may contain varying amounts of the active ingredient(s) depending upon the intended purpose; amounts of 0.01% to 10.0% and preferably 0.1% to 2%, by weight of active ingredient(s) are normally used.
A preferred form of concentrated composition comprises the active ingredient which has been finely divided and which has been dispersed in water in the presence of a surface-active agent and a suspending agent. Suitable suspending agents are hydrophilic colloids and include, for example, polyvinylpyrrolidone and sodium carboxymethylcellulose, and the vegetable gums, for example gum acacia and gum tragacanth. Preferred suspending agents are those which impart thixotropic properties to, and increase the viscosity of the concentrate. Examples of preferred
suspending agents include hydrated colloidal mineral silicates, such as montmorillonite, beidellite, nontronite, hectorite, saponite, and
saucorite. Bentonite is especially preferred. Other suspending agents include cellulose derivatives and polyvinyl alcohol.
The rate of application of the compounds of the invention will depend on a number of factors including, for example, the compound chosen for use, the identity of the plants whose growth is to be inhibited, the
formulations selected for use and whether the compound is to be applied for foliage or root uptak.. As a general guide, however, an application rate of from 0.0001 to 20 kilograms per hectare is suitable while from 0.001 to 10, for example 0.001 to 2 kilograms per hectare may be preferred.
The compositions of the invention may comprise, in addition to one or more compounds of the invention, one or more compounds not of the invention but which possess biological activity. Accordingly in yet a still further embodiment the invention provides a herbicidal composition comprising a mixture of at least one herbicidal compound of formula (I) (IA) or (IB) as hereinbefore defined with at least one other herbicide.
The other herbicide may be any herbicide not having the formula (I) (IA) or (IB). It will generally be a herbicide having a complementary action in the particular application.
Examples of useful complementary herbicides include:
A. benzo-2,1,3-thiadiazin-4-one-2,2-dioxides such as bentazone;
B. hormone herbicides, particularly the phenoxy alkanoic acids such as MCPA, MCPA-thioethyl, dichlorprop, 2,4,5-T, MCPB, 2,4-D, 2,4-DB, mecoprop, trichlopyr, clopyralid, and their derivatives (eg. salts, esters and amides);
C. 1,3 dimethylpyrazole derivatives such as pyrazoxyfen, pyrazolate and benzofenap;
D. Dinitrophenols and their derivatives (eg. acetates) such as dinoterb, dinoseb and its ester, dinoseb acetate;
E. dinitroaniline herbicides such as dinitramine, trifluralin,
ethalflurolin, pendimethalin, oryzalin;
F. arylurea herbicides such as diuron**, flumeturon, metoxuron, neburon, isoproturon**, chlorotoluron**, chloroxuron, linuron, monolinuron, chlorobromuron, daimuron, methabenzthiazuron;
G. phenylcarbamoyloxyphenylcarbamates such as phenmedipham and
desmedipham;
H. 2-phenylpyridazin-3-ones such as chloridazon and norflurazon;
I. uracil herbicides such as lenacil**, bromacil and terbacil;
J. triazine herbicides such as atrazine**, simazine, aziprotryne,
cyanazine, prometryn, dimethametryn, simetryne, and terbutryn;
K. phosphorothioate herbicides such as piperophos, bensulide, and
butamifos;
L. thiocarbamate herbicides such as cycloate, vernolate, molinate,
thiobencarb, butylate*, EPTC*, tri-allate, di-allate, esprocarb, tiocarbazil, pyridate, prosulfocarb** and dimepiperate;
M. 1,2,4-triazin-5-one herbicides such as metamitron and metribuzin;
N. benzoic acid herbicides such as 2,3,6-TBA, dicamba and chloramben;
O. anilide herbicides such as pretilachlor, butachlor, alachlor,
propachlor, propanil, metazachlor, metolachlor, acetochlor**, and dimethachlor;
P. dihalobenzonitrile herbicides such as dichlobenil, bromoxynil** and ioxynil; Q. haloalkanoic herbicides such as dalapon, TCA and salts thereof;
R. diphenylether herbicides such as lactofen, fluroglycofen or salts or ester thereof, nitrofen, bifenox, aciflurofen and salts and esters thereof, oxyfluorfen, fomesafen, chlornitrofen and chlomethoxyfen;
S. phenoxyphenoxypropionate herbicides such as diclofop and esters
thereof such as the methyl ester, fluazifop** and esters thereof, haloxyfop and esters thereof, quizalofop and esters thereof and fenoxaprop and esters thereof such as the ethyl ester;
T. cyclohexanedione herbicides such as alloxydim and salts thereof,
sethoxydim, cycloxydim, tralkoxydim**, and clethodim;
U. sulfonyl urea herbicides such as chlorsulfuron, sulfometuron,
metsulfuron and esters thereof; benzsulfuron and esters thereof such as DPX-M6313, chlorimuron and esters such as the ethyl ester thereof pirimisulfuron and esters such as the methyl ester thereof,
2-[3-(4-methoxy-6-methyl-1,3,5- triazin-zyl)-3-methylureidosulphonyl) benzoic acid esters such as the methyl ester thereof (DPX-LS300) and pyrazosulfuron;
V. imidazolidinone herbicides such as imazaquin, imazamethabenz, imazapyr and isopropylammonium salts thereof, imazethapyr;
W. arylanilide herbicides such as flamprop and esters thereof,
benzoylprop-ethyl, diflufenican**;
X. amino acid herbicides such as glyphosate and glufosinate and their salts and esters**, sulphosate (glyphosate trimesium)** and
bialaphos;
Y. organoarsenical herbicides such as monosodium methanearsonate (MSMA); Z. herbicidal amide derivative such as napropamide, propyzamide,
carbetamide, tebutam, bromobutide, isoxaben, naproanilide and naptalam;
AA triketones such as sulcotrione;
BB. miscellaneous herbicides including ethofumesate, cinmethylin,
difenzoquat and salts thereof such as the methyl sulphate salt, clomazone, oxadiazon, bromofenoxim, barban, tridiphane,
flurochloridone, quinchlorac and mefanacet;
CC. Examples of useful contact herbicides include:
bipyridylium herbicides such as those in which the active entity is paraquat and those in which the active entity is diquat;
* These compounds are preferably employed in combination with a safener such as dichlormid.
** These compounds have been demonstrated to exhibit additive and in several instances synergystic effects when applied in admixture with compounds of the present invention.
It is an advantage of preferred compounds of the present invention that they are compatible with a wide range of co-herbicides such as those listed above and may exhibit additive or synergystic effects in such mixtures.
The invention is illustrated by the following Examples.
EXAMPLE 1
The compounds listed in Table 1 were characterised by their NMR spectrum. In each case, the moiety derived from monic acid A (i.e. the
"normonyl" group of structure VI below) was characterised by a complex but readily identifiable spectrum which corresponded to that of Compound No 1, monic acid itself. Table II below lists the visible characterising features of the spectrum attributable to the different groups R2 although key peaks derived from the monic acid moiety may be included for
comparative identification. The solvent in which the spectrum was recorded is also given.
TABLE II
Compound Solvent 1H NMR δ
Number
2 CDCl3 5.9(1H,m); 5.2(2H,m); 4.6(2H,d)
3 d6-DMSO 4.0(2H,t); 3.5(2H,m)
4 CDCl3 2.3(3H,s)
5 CDCl3 6.5(1H,t); 4.3(2H,m); 3.9(2H,m); 3.8(2H,m)
6 CDCl3 4.0(2H,t); 2.2(3H,s)
7 CDCl3 8.0-7.5(5H,m); 4.2(2H,t); 2.2(2H,t)
8 d6-DMSO 4.6(2H,s)
9 CDCl3 4.8(2H,s)
10 CDCl3 7.7-7.4(4H,m); 5.2(2H,s)
11 CDCl3 7.6-7.2(4H,m); 5.1(2H,s)
12 CDCl3 7.3-7.1(4H,m); 5.1(2H,s); 2.2(3H,s)
13 CDC1, 7.4(4H,s); 5.1(2H,s); 4.7(2H,d) TABLE II (Continued)
Compound Solvent 1H NMR δ
Number
14 CDCl3 8.1-7.8(4H,m); 4.8(2H,d)
15 d6-DMSO 10.2(1H,s); 9.8(1H,s); 7.9(1H,s); 7.2(1H,d);
6.6(1H,s)
16 CDCl3 9.8(1H,s); 9.6(1H,s); 7.6(2H,d); 6.6(2H,d);
2.9(6H,s)
17 CDCl3 4.1(2H,t); 3.4(2H,t)
18 CDCl3 7.8(1H,s); 7.5(1H,s); 7.1(1H,d); 6.6(1H,s)
19 d6-DMSO 6.8(1H,s); 1.2(3H,t)
20 CDCl3 4.1(2H,t)
21 CDCl3 3.7(3H,s)
22 CDCl3 8.0(2H,d); 7.8(2H,d); 7.6(1H,s)
EXAMPLE 2
This Example illustrates the preparation of 2-Vinyloxyethyl monate A (Compound No 5 of Table 1).
Sodium monate A (lg, 2mM) was dissolved in dimethylformamide (25ml) and stirred with 2-chloroethylvinyl ether (0.6ml, 6mM), hexamethyl-phosphoramide (3 drops) and sodium iodide (0.9g) at 80°C for 6 hours.
After evaporation in vacuo the residue was partitioned between ethyl acetate and brine, and the aqueous phase further extracted with ethyl acetate (3×50ml). The combined organic fractions were washed with 10% sodium thiosulphate solution, saturated sodium bicarbonate solution and brine, dried (MgSO4) and evaporated in vacuo. Separation on silica (type 60, 20g) eluting with 0 to 4% methanol/CHCl3 gave the product, which crystallised on standing to give a solid of melting point 78-80°C. The NMR spectrum was as indicated in Example 1.
EXAMPLE 3
This Example illustrates the preparation of cyanomethyl monate A (Compound No 9 of Table 1).
A solution containing sodium monate A (2.00g, 5.4mmol),
chloroacetonitrile (0.35ml, 5.4mmol) and dimethylformamide (50ml) was stirred 1 hour at 80° and then evaporated in vacuo. The residue was taken up in ethyl acetate, which was washed with aqueous sodium bicarbonate and then brine, dried (MgSO4), evaporated in vacuo, and purified by
chromatography (0 to 4% methanol in chloroform, 20g silica gel) to give the desired product as a clear oil. The NMR spectrum was as indicated in Example 1.
EXAMPLE 4
This Example illustrates the preparation of 3-bromobenzyl monate A (Compound No 11 of Table 1).
A solution containing sodium monate A (1.1gm 3mmol), m-bromobenzyl bromide (0.75g, 3mmol), and dimethylformamide (35ml) was stirred at 20°C for 5 hours and then evaporated in vacuo. The resiude was taken up in ethyl acetate/brine, the organic layer washed with aqueous sodium
bicarbonate, then brine, dried (MgSO4), evaporated in vacuo, and purified by chromatography (0 to 6% methanol in dichloromethane, 20g silica gel) to give the desired product as a colourless oil which solidified to yield white powder of melting point 91°C-92°C. The NMR spectrum was as indicated in Example 1.
EXAMPLE 4
This Example illustrates the preparation of 3-methylbenzyl monate A (Compound No 12 of Table 1).
A solution containing sodium monate A (0.73g, 2mmol), α-bromo-m-xylene (0.37g, 2mmol) and dimethylformamide (25ml) was stirred at 20°C for
17 hours and then evaporated in vacuo. The residue was taken up in ethyl acetate/brine, the organic phase washed with aqueous sodium bicarbonate and then brine, dried (MgSO4) and evaporated in vacuo. The residual oil was purified by chromatography (0 to 4% methanol in dichloromethane, 15g silica gel) to yield the desired product as a colourless oil. The NMR spectrum was as indicated in Example 1.
EXAMPLE 5
This Example illustrates the preparation of 4-hydroxymethylbenzyl monate A (Compound No 13 of Table 1).
p-Toluic acid (13.6g, 100mmol) was refluxed in methanol (95ml) and concentrated sulphuric acid (5ml) for Vk hours. The reaction was
evaporated to half volume, poured into water, extracted with ethyl acetate, dried (MgSO4), and evaporated in vacuo. To the residue was added
N-bromosuccinimide (17.8g, 100mmol), benzoyl peroxide (100mg) and carbon tetrachloride (50ml) and refluxed for 2½ hours. The reaction was then filtered, and the filtrate evaporated in vacuo. The product, methyl-4-bromomethylbenzoate (9.2g, 40mmol) in toluene (80ml) was cooled to -30°C and a solution of diisobutyl aluminium hydride in toluene (60ml, 25%, 80mmol) was added dropwise and stirred for 1 hour. The solution was allowed to warm to room temperature and stirred a further 2 hours. The reaction was then quenched with methanol, filtered, and the filtrate washed with aqueous sodium bicarbonate solution and then brine. The orgnaic layer was dried (MgSO4) and evaporated in vacuo to yield
4-bromomethylbenzyl alcohol.
A solution containing sodium monate A (4mmol) and 4-bromomethylbenzyl alcohol (4mmol) in dimethylformamide (60ml) was stirred overnight at room temperature, and then evaporated in vacuo. The residue was taken up in ethyl acetate/brine, washed with aqueous sodium bicarbonate and then brine, dried and evaporated. The residue was purified by chromatography, eluting with methanol/dichloromethane mixtures to yield a colourless oil. The NMR spectrum was as indicated in Example 1.
EXAMPLE 6
This Example illustrates the preparation of 4-dimethylaminobenzoyl-monhydrazide A (Compound No 16 of Table 1).
Monic acid A (3.44g, 10mmol) was dissolved in tetrahydrofuran (100ml) and cooled to 0°C. Triethylamine (1.5ml, 11mmol) and isobutylchloroformate (1.4ml, 11mmol) were added and stirred for 30 minutes. Dimethylamino-benzahydrazide (1.79g, 10mmol) was added and the reaction mixture stirred for 5 hours. The reaction mixture was then filtered and evaporated under reduced pressure. The residue was crystallised from ether to yield the desired product as a white solid of melting point 116-118°C. The NMR spectrum was as indicated in Example 1.
EXAMPLE 7
This Example illustates the preparation of 1-bromo-8-octyl monate A (Compound No 17 of Table 1).
A solution containing sodium monate A (1.0g, 2.7mmol) and
1,8-dibromooctane (0.75g, 2.7mmol) in dimethylformamide (5ml) was stirred overnight at room temperature and then evaported under reduced pressure. The residue was dissolved in ethyl acetate/water and the organic layer washed with water, dried (MgSO4) and evaporated under reduced pressure. The resulting residue was purified by column chromatography (silica gel, eluting with 0 to 3% methanol in dichloromethane) to yield the desired product as an oil. The NMR spectrum was as indicated in Example 1. EXAMPLE 8
The Example illustrates the preparation of cetyl monate A (Compound No 20 of Table 1).
Monic acid A (25.8g, 75mmol), potassium carbonate (10.5g, 76mmol), sodium iodide (15.0g, 100mmol) and cetyl bromide (45ml, 147mmol) were stirred in dimethylformamide (750ml) and hexamethylphosphoramide (150 drops) for 24 hours. The mixture was diluted with ethyl acetate (1.51), washed with water (4 × 0.51) and brine, dried and evaporated. The residue was purified on silica (1200g), eluting with 5% methanol in chloroform, to give a fine white powder. This was recrystallised from ethyl
acetate/hexane to give the desired product. The NMR spectrum was as indicated in Example 1.
EXAMPLE 9
This Example illustrates the preparation of pent-4-enyl monate A (Compound No 25 of Table I).
Sodium monate A (160mg, 0.44mM) was dissolved in dimethylformamide (2ml) and stirred with 1-bromopent-4-ene (131mg, 0.88mM) and
N,N-dimethylpropyleneurea (0.38ml) at room temperature for 4 hours and then at 70°C for 2 hours. Volatile components were removed by evaporation in vacuo. Separation on silica eluting with 55:45 acetone/hexane gave the desired product as a colourless syrup.
1H NMR δ(CDCl3): 5.82 (1H, m), 5.77 (1H, s), 5.08 (1H, d), 5.00 (1H, d), 4.11 (2H, t), 2.21 (3H, s), 1.22 (3H, d), 0.95 (3H, d).
EXAMPLES 10 TO 15
The following compounds were prepared using the general method of Example 9:
4-Methoxybenzyl monate A (Compound No 55 of Table I)
1H NMR δ(CDCl3) 7.30 (2H, d), 6.88 (2H, d), 5.79 (1H, s), 5.07 (2H, s), 3.90 (3H, s), 2.21 (3H, s), 1.22 (3H, d), 0.92 (3H, d).
3-Nitrobenzyl monate A (Compound No 70 of Table I)
1H NMR δ(CDCl3) 8.28 (1H, s), 8.20 (1H, d), 7.70 (1H, d), 7.54 (1H, t), 5.80 (2H, s), 2.22 (3H, s), 1.21 (3H, d), 0.93 (3H, d),
Propargyl monate A (Compound No 71 of Table I)
1Η NMR δ(CDCl3) 5.80 (1H, s), 4.71 (2H, s), 2.22 (3H, s), 1.21 (3H, d),
0.94 (3H, d). Ethyl acet-2-yl monate A (Compound No 72 of Table I)
1H NMR δ(CDCl3) 5.89 (1H, s), 4.63 (2H, abq), 4.22 (2H, q), 2.22
(3H, s), 1.29 (3H, t), 1.22 (3H, d), 0.91 (3H, d).
Decyl monate A (Compound No 73 of Table I)
1H NMR δ(CDCl3) 5.78 (1H, s), 4.08 (2H, t), 2.21 (3H, s), 1.21 (3H, d),
0.95 (3H, d), 0.87 (3H, t).
2-Phenoxyethoxy monate A (Compound No 27 of Table 1)
1H NMR δ(CDCl3) 7.29 (2H, t), 6.91 (3H, m), 5.81 (1H, s) 4.46 (3H, t), 4.19 (3H, t), 2.22 (3H, s), 1.21 (3H, d), 0.92 (3H, d).
EXAMPLE 16
This Example illustrates the preparation of prop-2-yl monate A
(Compound No 36 of Table I).
Sodium monate A (200mg, 0.55mM) was dissolved in dimethylformamide (2ml) and stirred with 2-bromopropane (136mg, 1.11mM),
N,N-dimethylpropyleneurea (0.476g) and sodium iodide (166mg, 1.11mM) at room temperature for 1.5 hours and then left to stand for 4 days. Volatile components were removed by evaporation in vacuo. Separation on silica eluting with 55:45 acetone/hexane gave the desired product as a colourless syrup.
1H NMR δ(CDCl3) 5.72 (1H, s), 5.02 (1H, m), 2.21 (3H, s), 1.24 (6H, d), 1.22 (3H, d), 0.94 (3H, d).
EXAMPLES 17 TO 19
The following compounds were prepared in a manner corresponding to that to Example 16:-
2-Ethoxyethyl monate A (Compound No 26 of Table I)
1H NMR δ(CDCl3) 5.81 (1H, s), 4.26 (2H, t), 3.66 (2H, t), 3.54 (2H, t),
2.21 (3H, s), 1.22 (3H, m), 1.21 (3H, d), 0.94 (3H, d).
Pent-4-ynyl monate A (Compound No 31 of Table I)
1H NMR δ(CDCl3) 5.78 (1H, s), 4.20 (2H, t), 2.21 (3H, s), 1.22 (3H, d),
0.94 (3H, d).
Ethyl propion-2-yl monate A (Compound No 45 of Table I), obtained as a mixture of diastereoisomers.
1H NMR δ(CDCl3) 5.86 (1H, s), 5.09 (1H, m), 4.21 (2H, q), 2.21 (3H, s), 1.50 (3H, d) , 1.25 (3H, t) , 1.22 (3H, d) , 0.92 (3H, d) .
EXAMPLE 20
This Example illustrates the preparation of 2-(4-chlorophenoxy)ethyl monate A (Compound No 28 of Table I)
Monic acid A (200mg, 0.58mM) was dissolved in dimethylformamide (1ml) and stirred with 2-(4-chlorophenoxy)ethyl bromide (273mg, 1.16mM) and N,N-dimethylpropyleneurea (510mg, 3.98mM). Potassium carbonate (120mg, 0.87mM) was added and the mixture stirred at room temperature for 1 hour and at 80°C for 1.5 hours. Volatile components were removed by evaporation in vacuo. Separation on silica eluting with 55:45 acetone/hexane gave the desired product as a gum.
1H NMR δ(CDCl3) 7.25 (2H, d), 6.82 (2H, d), 5.80 (1H, s), 4.40 (2H, m), 4.16 (2H, m), 2.22 (3H, s), 1.21 (3H, d), 0.93 (3H, d).
EXAMPLES 21 TO 32
The following compounds were prepared using the general method of Example 20:
2-((2-methoxy)ethoxy)ethyl monate A (Compound No 42 of Table I)
1H NMR δ(CDCl3) 5.81 (1H, s), 4.27 (2H, t), 3.72 (2H, t), 3.65 (2H, m), 3.55 (2H, m), 3.40 (3H, s), 2.21 (3H, s), 1.21 (3H, d), 0.95 (3H, d).
A (1:4) mixture of 1-methylprop-2-enyl monate A (Compound No 49 of Table I - itself a mixture of diastereoisomers) and but-2-enyl monate A (Compound No 48 of Table I - itself a mixture of geometrical isomers)
1-methylprop-2-enyl monate A
1H NMR δ(CDCl3) 5.78 (1H, m), 5.39 (1H, m), 5.25 (1H, m), 5.15 (1H, m),
2.21 (3H, s), 1.70 (3H, s), 1.21 (3H, d), 0.99 and 0.80 (3H, 2×d).
But-2-enyl monate A
1H NMR δ(CDCl3) 5.78 (1H, m), 5.60 (1H, m), 4.63 and 4.52 (2H, 2×d),
2.21 (3H, s), 1.21 (3H, d), 0.95 (3H, d).
2-(Ethoxycarbonylmethoxy)ethyl monate A (Compound No 30 of Table 1)
1H NMR δ(CDCl3) 5.80 (1H, s), 4.29 (2H, t), 4.23 (2H, q), 4.14 (2H, s),
3.80 (2H, t), 2.23 (3H, s), 1.28 (3H, t), 1.23 (3H, d), 0.94 (3H, d). 2-(Acetoxy)ethyl monate A (Compound No 29 of Table 1)
1H NMR δ(CDCl3) 5.78 (1H, s), 4.28 (4H, s), 2.23 (3H, s), 2.08 (3H, s),
1.22 (3H, d), 0.94 (3H, d).
2-(Carbamoylmethoxy)ethyl monate A (Compound No 46 of Table 1)
1H NMR δ(CDCl3) 6.65 (1H, s), 6.50 (1H, s), 5.86 (1H, d), 4.54 (2H, s),
2.22 (2H, s), 1.21 (3H, d), 0.92 (3H, d).
3-Chloroprop-2-en-1-yl monate A (Compound No 47 of Table 1)
1H NMR δ(CDCl3) 6.37-5.91 (2H, m), 5.79 (1H, s), 5.81 & 4.59 (2H, 2 d), 2.21 (3H, s), 1.22 (3H, d), 0.94 (3H, d).
Ethyl monate A (Compound No 35 of Table 1)
1H NMR δ(CDCl3) 5.75 (1H, s), 4.12 (2H, q), 2.21 (3H, s), 1.29 (3H, t),
1.21 (3H, d), 0.93 (3H, d).
Butyl monate A (Compound No 37 of Table 1)
1H NMR δ(CDCl3) 5.75 (1H, s), 4.10 (2H, t), 2.20 (3H, s), 1.65 (2H, m),
1.38 (2H, m), 1.21 (3H, d), 0.92 (6H, m).
Cyclohexyl monate A (Compound No 39 of Table 1)
1H NMR δ(CDCl3) 5.73 (1H, s), 4.78 (1H, m), 2.21 (3H, s), 1.80-1.20
(10H, s), 1.22 (3H, d), 0.94 (3H, d).
Ethoxymethyl monate A (Compound No 76 of Table 1).
1H NMR δ(CDCl3) 5.79 (1H, s), 5.30 (2H, s), 2.22 (3H, s), 1.22 (3H, d),
0.92 (3H, d).
EXAMPLE 33
This Example illustrates the preparation of 2-(allyloxy)ethyl monate A (Compound No 23 of Table I)
Stage 1 Preparation of 1-Mesyloxy-2-allyloxyethane
2-Allyloxyethanol (5.0g, 49mM) was stirred with triethylamine (5.2g, 51mM) in dichloromethane (25ml) at 0°C under nitrogen. Methanesulphonyl chloride (5.61g, 49mM) was added slowly with stirring. The cooling bath was removed at the mixture stirred at room temperature for a further 1 hour. Volatile components were removed by evaporation in vacuo. The residue was partitioned between diethyl ether and water. The organic fraction was washed twice with water and once with brine, dried (MgSO4) and evaporated in vacuo. The product was a yellow oil.
Stage 2 Preparation of 2-(allyloxy)ethyl monate A
Sodium monate A (165mg, 0.45mM) was dissolved in dimethylformamide (2ml) and stirred with 1-mesyloxy-2-allyloxyethane (162mg, 0.90mM) and N,N-dimethylpropyleneurea (0.39ml) at room temperature for 19 hours.
Volatile components were removed by evaporation in vacuo. Separation on silica eluting with 55:45 acetone/hexane gave the desired product as a colourless oil.
1H NMR δ(CDCl3) 5.90 (1H, m), 5.81 (1H, s), 5.27 (1H, d), 5.20 (1H, d), 4.27 (2H, t), 4.05 (2H, d), 3.75 (2H, t), 2.21 (3H, s), 1.22 (3H, d), 0.92 (3H, s).
EXAMPLES 34 TO 37
The following compounds were prepared using the general method of Example 33:-
3-Vinyloxypropyl monate A (Compound No 33 of Table 1)
1H NMR δ(CDCl3) 6.46 (1H, dd), 5.76 (1H, s), 4.19 (3H, m), 4.01
(1H, dd), 3.79 (2H, t), 2.21 (3H, s), 1.23 (3H, d), 0.95 (3H, d).
2-(3-Chloroprop-2-en-1-yloxy)ethyl monate A No 44 of Table 1)
1H NMR δ(CDCl3) 6.20 (1H, d), 5.95 (1H, q), 5.81 (1H, s), 4.27 (4H, m),
3.70 (2H, t), 2.22 (3H, s), 1.22 (3H, d), 0.94 (3H, d).
4-Vinyloxybut-1-yl monate A (Compound No 32 of Table 1)
1H NMR δ(CDCl3) 6.46 (1H, abq), 5.74 (1H, s), 4.11 (2H, m), 2.21
(3H, s), 1.20 (3H, d), 0.92 (3H, d).
2-(prop-2-yn-1-yloxy)ethyl monate A (Compound No 43 of Table 1)
1H NMR δ(CDCl3) 5.80 (1H, s), 4.28 (2H, t), 4.21 (2H, d), 3.79(2H, t) 2.48 (1H, t), 2.21 (3H, s), 1.21 (3H, d), 0.94 (3H, d).
EXAMPLE 38
This Example illustrates the preparation of N,N-Diethyl-monicamide A (Compound No 63 of Table I)
Monic acid A (200mg, 0.58mM) was dissolved in tetrahydrofuran (5ml) and cooled to -10°C under nitrogen. Triethylamine (59mg, 0.58mM) and isobutylchloroformate (80mg, 0.58mM) were added and stirred for 30 minutes. A solution of diethylamine (47mg, 0.58mM) in tetrahydrofuran (0.5 ml) was added an the reaction mixture stirred for 1 hour and then at room
temperature for 2 hours. The reaction mixture was filtered and evaporated in vacuo. Thin layer chromatography indicated that the reaction was incomplete so further diethylamine (20mg) in tetrahydrofuran (3ml) was added and the mixture stood at room temperature overnight. Volatile components were removed by evaporation in vacuo. The residue was taken up in water (10ml) and extracted with chloroform (3×10ml). The combined organic extracts were dried (MgSO4) and evaporated in vacuo. The resulting residue was purified by column chromatography (silica gel, eluting with methanol/chloroform 1:9) to give the desired product as a colourless gum.
1H NMR δ(CDCl3) 5.87 (1H, s), 1.91 (3H, s), 1.21 (3H, d), 1.12 (6H, m), 0.92 (3H, d).
EXAMPLES 39 TO 56
The following compound was prepared using the general method of Example 38:
Monic acid A morpholine amide (Compound No 64 of Table I)
1H NMR δ(CDCl3) 5.81 (1H, s), 3.67-3.47 (8H, m), 1.90 (3H, s), 1.21 (3H, d), 0.94 (3H, d).
N-(2,4-Dichlorophenyl)-N-methylmonic amide A (Compound No 60 of Table 1)
1H NMR δ(CDCl3) 7.50-7.15 (3H, m), 5.49 (1H, s), 3.20 (3H, s), 2.18 (3H, s), 1.22 (3H, d), 0.95 (3H, d).
N-(2-Hydroxyethyl)monicamide A (Compound No 77 of Table 1).
1H NMR δ(d6-DMSO) 7.89 (1H, t), 5.81 (1H, s), 4.51 (4H, m), 2.21 (3H, s),
1.21 (3H, d), 0.95 (3H, d).
N-(2-Ethoxyethyl)monicamide A (Compound No 78 of Table 1).
1H NMR δ(d6-DMSO) 6.21 (1H, t), 5.68 (1H, s), 3.62-3.42 (6H, m), 2.20
(3H, s), 1.20 (6H, m), 0.92 (3H, d).
N-(Ethoxycarbonylmethyl)monicamide A (Compound No 66 of Table 1)
1H NMR δ(CDCl3) 6.24 (1H, t), 5.73 (1H, s), 4.23 (2H, q), 4.0<
2.19 (3H, s), 1.30 (3H, t), 1.22 (3H, d), 0.92 (3H, d).
Monicamide A (Compound No 61 of Table 1)
1H NMR δ(d4-MeOH) 5.93 (1H, s), 2.29 (3H, s), 1.35 (3H, d), 1.10 (3H, d). N-(2,4-Dichlorophenyl)monicamide A (Compound No 58 of Table 1)
1H NMR δ(d4-MeOH) 7.99 (1H, d), 7.63 (1H, d), 7.45 (1H, dd), 6.20 (1H, s),
2.38 (3H, s), 1.33 (3H, d), 1.10 (3H, d).
N,N-bisallylmonicamide A (Compound No 79 of Table 1).
1H NMR δ(CDCl3) 5.89 (1H, s), 5.76 (2H, m), 5.16 (4H, m), 1.97 (3H, s),
1.22 (3H, d), 0.93 (3H, d).
Monic acid A piperidine amide (Compound No 80 of Table 1).
1H NMR δ(CDCl3) 5.81 (1H, s), 3.50 (4H, m), 1.85 (3H, s), 1.60 (6H, m),
1.21 (3H, d), 0.92 (3H, d).
Monic acid A N-methylpiperazine amide (Compound No 81 of Table 1).
1H NMR δ(d4-MeOH) 5.99 (1H, s), 3.72 (4H, m), 2.56 (4H, t), 2.44 (3H, s),
1.97 (3H, s), 1.32 (3H, d), 1.06 (3H, d).
N,N-Dimethylmonichydrazide A (Compound No 82 of Table 1).
1H NMR δ(CDCl3) 5.52 (1H, s), 2.40 (6H, s), 2.04 (3H, s), 1.10 (3H, d):
0.83 (3H, d).
Monichydrazide A (Compound No 65 of Table 1)
1H NMR δ(d4-MeOH) 5.80 (1H, s), 2.28 (3H, s), 1.30 (3H, d), 1.04 (3H, d).
N-(Prop-2-ylidiene)monichydrazone A (Compound No 83 of Table 1).
1H NMR δ(d4-MeOH) 6.84 (1H, s), 5.76 (1H, s), 2.33 (3H, s), 2.20 (3H, s),
2.12 (3H, s), 1.35 (3H, d), 1.10 (3H, d).
N-(2,5-Dichlorophenyl)monicamide A (Compound No 59 of Table 1)
1H NMR δ(d6-DMSO) 9.42 (1H, s), 7.86 (1H, d), 7.46 (1H, d), 7.18 (1H, dd),
6.05 (1H, s), 2.21 (3H, s), 1.02 (3H, d), 0.80 (3H, d).
Monic acid A pyrrolidine amide (Compound No 84 of Table 1).
1H NMR δ(CDCl3) 5.88 (1H, s), 3.46 (4H, m), 2.08 (3H, s), 1.90 (4H, m),
1.21 (3H, d), 0.92 (3H, d). Monic acid A 2,6-dimethylmorpholine amide (Compound No 85 of Table 1).
1H NMR δ(CDCl3) 5.80 (1H, s), 3.50 (6H, m), 1.85 (3H, s), 1.20 (9H, m),
0.93 (3H, d).
N-Allylmonicamide A (Compound No 86 of Table 1).
1H NMR δ(CDCl3) 5.92-5.72 (2H, m), 5.68 (1H, s), 5.22-5.10 (2H, m), 3.10
(2H, m), 2.18 (3H, s), 1.21 (3H, d), 0.92 (3H, d).
N,N-bis(2-hydroxyethyl)monicamide A (Compound No 87 of Table 1).
1H NMR δ(d6-DMSO) 5.90 (1H, s), 3.40 (4H, m), 3.30 (4H, m), 1.80 (3H, s),
1.10 (3H, d), 0.78 (3H, d)
EXAMPLE 57
This Example illustrates the preparation of S-(carbomethoxymethyl) thiomonate A (Compound No 75 of Table I).
Monic acid A (80mg, 0.23mM) was dissolved in tetrahydrofuran (3ml) and cooled to -10°C under nitrogen. Triethylamine (24mg, 0.23mM) and a solution of isobutylchloroformate (32mg, 0.23mM) in tetrahydrofuran (0.7ml) were added and stirred for 20 minutes. A solution of methylthioglycolate (25mg, 0.23mM) in tetrahydrofuran (0.5 ml) was added an the reaction mixture stirred for 1 hour and then at room temperature for 3 hours. The reaction mixture was evaporated in vacuo and the resulting residue stored at room temperature for 7 days. The mixture was purified by column chromatography (silica gel, eluting with methanol/chloroform 1:9) to give the desired product as a colourless gum (67 mg, 67%).
1H NMR δ(CDCl3) 6.10 (1H, s), 4.76 (3H, s), 4.74 (2H, s), 2.21 (3H, s), 1.22 (3H, d), 0.93 (3H, d).
EXAMPLES 58 AND 59
The following compounds were prepared using the general method of Example 57:
S-Phenylthiomonate A (Compound No 74 of Table 1)
1H NMR δ(CDCl3) 7.42 (5H, s), 6.18 (1H, s), 2.20 (3H, s), 1.22 (3H, d),
0.92 (3H, d).
S-(2-Vinyloxyethyl)thiomonate A (Compound No 68 of Table 1)
1H NMR δ(CDCl3) 6.45 (1H, dd), 6.07 (1H, s), 5.80 (2H, s), 3.18 (2H, t),
2.21 (3H, s), 1.73 (2H, t), 1.21 (3H, d), 0.95 (3H, d). EXAMPLE 60
This Example illustrates the preparation of 3-Nitrophenyl monate A (Compound No 52 of Table 1).
Monic acid A (200mg, 0.58mM) was dissolved in tetrahydrofuran (5.5ml) and cooled to -10°C under nitrogen. Triethylamine (59mg, 0.58mM) and isobutylchloroformate (80mg, 0.58mM) were added and stirred for 10 minutes and then at room temperature for 1 hour. Solids were removed by filtration and the filtrate concentrated in vacuo. The residue was taken up in dichloromethane (2.5ml) and 3-nitrophenol (323mg, 2.32mM) added. A solution of pyridine (35mg) in dichloromethane (0.5ml) was added to give a clear homogeneous solution and the mixture was stirred at room temperature overnight. Solvents were removed in vacuo and separated on silica eluting with 55:45 acetone/hexane to give the desired product.
1H NMR δ(CDCl3) 8.10 (1H, d), 8.02 (1H, m), 7.54 (1H, t), 7.47 (1H, d), 6.02 (1H, s), 2.19 (3H, s), 1.22 (3H, d), 0.95 (3H, d).
EXAMPLES 61 TO 67
The following compounnds were preared using the general method of Example 60:
Phenyl monate A (Compound No 50 of Table 1)
1H NMR δ(CDCl3) 7.39 (2H, t), 7.21 (1H, t), 7.10 (2H, d), 6.00 (1H, s),
2.28 (3H, s), 1.21 (3H, d), 0.93 (3H, d).
Furfuryl monate A (Compound No 56 of Table 1)
1H NMR δ(CDCl3) 7.42 (1H, s), 6.41 (1H, d), 6.32 (1H, t), 5.79 (1H, s),
5.08 (2H, s), 2.22 (3H, s), 1.21 (3H, d), 0.94 (3H, d).
Neopentyl monate A (Compound No 38 of Table 1)
1H NMR δ(CDCl3) 5.78 (1H, s), 3.79 (2H, s), 2.21 (3H, s), 1.21 (3H, d),
0.95 (12H, m).
2-Chloroethyl monate A (Compound No 57 of Table 1)
1H NMR δ(CDCl3) 5.81 (1H, s), 4.37 (2H, t), 3.72 (2H, t), 2.24 (3H, s),
1.22 (3H, d), 0.98 (3H, d).
4-Methoxyphenyl monate A (Compound No 53 of Table 1)
1H NMR δ(CDCl3) 7.01 (2H, d), 6.88 (2H, d), 5.97 (1H, s), 3.80 (3H, s),
2.26 (3H, s), 1.22 (3H, d), 0.94 (3H, d). 4-Chlorophenyl monate A (Compound No 51 of Table 1)
1H NMR δ(CDCl3) 7.28 (2H, d), 6.97 (2H, d), 5.91 (1H, s), 2.20 (3H, s),
1.15 (2H, d), 0.88 (2H, d).
2-(Vinylthio)ethyl monate A (Compound No 67 of Table 1)
1H NMR δ(CDCl3) 6.33 (1H, dd), 5.78 (1H, s), 5.28 (1H, d), 5.20 (1H, d), 4.28 (2H, t), 2.95 (2H, t), 2.21 (3H, s), 1.21 (3H, d), 0.95 (3H, d).
EXAMPLE 68
The following Example illustrates the preparation of Monic acid A trimethylsulphonium salt (Compound No 88 of Table 1).
Trimethylsulphonium iodide (59mg, 0.29mM) was dissolved in water (5ml) and treated with Dowex 1×2 (HO-) resin for 10 minutes. The solution was filtered into a solution of monic acid A (100mg, 0.29 mM) in water (10ml). The solution was freeze-dried to give the desired product.
1H NMR δ(D2O) 5.70 (1H, s), 2.83 (9H, s), 1.90 (1H, s), 1.16 (3H, d), 0.91 (3H, d).
EXAMPLE 69
The following Example illustrates the preparation of
4-(Methoxycarbonyl)phenyl monate A (Compound No 54 of Table 1).
Monic acid A (250mg, 0.72mM) was dissolved in dichloromethane (3ml). A solution of triethylamine (74mg, 0.73mM) in dichloromethane (1ml) was added and the mixture stirred at room temperature for 5 minutes. The reaction mixture was cooled in an ice/water bath and a solution of
isoprenylchloroformate (88mg, 0.73mM) in dichloromethane (1ml) added slowly and the mixture stirred with cooling for a further 10 minutes.
4-(Methoxycarbonyl)phenol (166mg, 1.09mM) and N,N-dimethylaminopyridine (9mg) were added and the mixture stirred for a further 2 hours with cooling. The crude reaction mixture was separated on silica eluting with 55:45 acetone/hexane to give the desired product.
1H NMR δ(CDCl3) 8.08 (2H, d), 7.18 (2H, d), 5.99 (1H, s), 3.91 (3H, s), 2.27 (3H, s), 1.21 (3H, d), 0.93 (3H, d).
EXAMPLE 70
The following Example illustrates the preparation of 2-Vinyloxyethyl pseudomonate A (Compound No 89 of Table 1).
Pseudomonic acid A (200mg, 0.40mM) was dissolved in acetone (2ml) and stirred with 1-chloro-2vinyloxyethane (85mg, 0.60mM) and sodium iodide (132mg, 88mM). Potassium carbonate (83mg, 0.60mM) was added and the mixture stirred at room temperature for 2 hours and at reflux overnight. Volatile components were removed by evaporation in vacuo. The residue was taken up in dimethylformamide (1ml) and N,N-dimethylpropyleneurea
(0.5ml) and heated at 80°C for 4 hours. Further portions of
1-chloro-2-vinyloxyethane (85mg, 0.60mM) and sodium iodide (120mg) were added and heating continued for 8 hours. The reaction mixture was
partitioned between water and diethylether and the organic layer was washed with water and brine and then dried over magnesium sulphate. Separation on silica eluting with 55:45 acetone/hexane gave the desired product as a gum.
1H NMR δ(CDCl3) 6.49 (1H, m), 5.76 (1H, s), 4.32 (2H, t), 4.20 (1H, dd), 4.08 (2H, t), 2.32 (2H, t), 2.20 (3H, s), 1.21 (3H, d), 0.95 (3H, d).
EXAMPLES 71 AND 72
The following compounds were prepared using the general method of Example 70:
Ethyl pseudomonate A (Compound No 90 of Table 1).
1H NMR δ(CDCl3) 5.79 (1H, s), 4.15 (2H, q), 4.11 (2H, t), 2.28 (2H, t),
2.21 (3H, s), 0.95 (3H, d).
2-Hydroxyethyl pseudomonate A (Compound No 91 of Table 1).
1H NMR δ(CDCl3) 5.78 (1H, s), 4.21 (2H, t), 4.08 (2H, t), 2.32 (2H, t), 2.21 (3H, s), 1.21 (3H, d), 0.95 (3H, d).
EXAMPLE 73
The following Example illustrates the preparation of N,N-Diethyl pseudomonicamide A (Compound No 92 of Table 1).
Pseudomonic acid A (200mg, 0.40mM) was dissolved in tetrahydrofuran (4ml) and cooled to -10°C under nitrogen. Triethylamine (41mg, 0.40mM) and isobutylchloroformate (55mg, 0.40mM) were added and stirred for 30 minutes. A solution of diethylamine (32mg, 0.40mM) in tetrahydrofuran (2ml) was added an the reaction mixture stirred for 30 minutes and then stood at room temperature overnight. The reaction mixture was filtered and evaporated in vacuo. The residue was taken up in water (10ml) and extracted with chloroform (3x10ml). The combined organic extracts were dried over magnesium sulphate and evaporated in vacuo. The resulting residue was purified by column chromatography (silica gel, eluting with acetone/hexane 55:45) to give the product as a colourless gum.
1H NMR δ(CDCl3) 5.78 (1H, s), 4.08 (2H, t), 3.31 (4H, q), 2.28 (2H, t), 2.21 (3H, s), 1.22 (6H, t), 0.95 (3H, d). EXAMPLE 74
This example illustrates the preparation of monic acid A
isopropylamine salt (Compound No 96 of Table 1)
Monic acid A (50mg, 0.15mM) was dissolved in tetrahydrofuran (2ml) and was treated with isopropylamine (8.6mg, 0.15mM). After 20 minutes at room temperature, a precipitate formed which was collected by filtration to give the desired product.
1H NMR δ(CDCl3) 5.76 (1H, s), 2.21 (3H, s), 1.21 (3H, d), 1.10 (6H, d),
0.93 (3H, d).
EXAMPLES 75 AND 76
The following compounds were prepared using the general method of
Example 74:
Monic acid A triethylamine salt (Compound No 97 of Table 1)
1H NMR δ(CDCl3) 5.80 (1H, s), 2.88 (6H, q), 2.13 (3H, s), 1.20 (12H, m),
0.92 (3H, d).
Pseudomonic acid A triethylamine salt (Compound No 98 of Table 2)
1H NMR δ(CDCl3) 5.78 (1H, s), 4.08 (2H, t), 3.00 (6H, q), 2.21 (3H, s),
1.25 (9H, t), 0.94 (3H, d).
EXAMPLE 77
This Example illustrates the preparation of Monic acid A sodium salt (Compound No 99 of Table 1)
Monic acid A (1.2g, 3.48mM) was suspended in water (35ml) and was treated with an aqueous 0.1M solution of sodium hydroxide (34.8ml, 3.48mM). The solution was freeze dried to give the desired product as a white solid.
1H NMR δ(D2O) 5.69 (1H, s), 1.85 (1H, s), 1.15 (3H, d), 0.90 (3H, d).
EXAMPLE 78
This Example illustrates the preparation of 2-ethoxyethyl monate C (Compound No 108 of Table 3) from monic acid C (Compound No 107 of Table 3)
Monic acid C (1.62g, 0.49mM) was taken up in a mixture of
dimethylformamide (1ml) and N,N-dimethylpropyleneurea (0.43ml). Potassium carbonate (0.102g, 0.74mM) was added and the reaction mixture stirred for 1 hour at 80-90°C. After cooling to room temperature, a solution of
2-chloroethylethylether (0.107g, 0.99mM) in dimethylformamide (0.5ml) was added and the mixture stirred at room temperature for 19 hours, at 90°C for 6 hours and then left to stand at room temperature overnight. Volatile components were removed in vacuo and the residue separated on silica, eluting with acetone/hexane (1:1) to give the desired product as a gum.
1H NMR δ(CDCl3) 5.81 (1H, s), 5.45 (2H, d), 4.25 (2H, t), 3.75 (2H, t), 2.22 (3H, s), 1.23 (3H, t), 1.17 (3H, d), 1.00 (3H, d).
EXAMPLES 79 TO 87
The following compounds were prepared using the general method of Example 20:-
2-(Hex-2-en-1-yl)ethyl monate A (Compound No 94 of Table 1)
1H NMR δ(CDCl3) 5.80 (1H, s), 5.30-5.60 (2H, m), 4.22 (2H, t), 2.21
(3H, s), 1.21 (3H, d), 0.95 (6H, m).
Cyclopropylmethyl monate A (Compound No 93 of Table 1)
1H NMR δ(CDCl3) 5.80 (1H, s), 3.92 (2H, d), 2.23 (3H, s), 1.23 (3H, d)
0.94 (3H, d), 0.57 (2H, m), 0.29 (2H, m).
(E/Z) 2-(Prop-1-en-1-yloxy)ethyl monate A (1:1) (Compound No 24 of Table 1)
1H NMR δ(CDCl3) 6.24 and 5.79 (1H, 2 × d), 5.80 (1H, s), 4.81 and 4.44 (1H, 2 × m),426 (2H, m), 2.23 (3H, s), 1.23 (3H, d), 0.95 (3H, d).
2-(Prop-2-yloxy)ethyl monate A (239075) (Compound No 100 of Table 1)
1H NMR δ(CDCl3) 5.81 (1H, s), 4.22 (2H, m), 3.63 (2H, t), 2.22 (3H, s),
1.23 (3H, d), 1.18 (6H, d), 0.95 (3H, d).
2-Methoxyethyl monate A (Compound No 101 of Table 1)
1H NMR δ(CDCl3) 5.83 (1H, s), 4.25 (2H, t), 3.60 (2H, t), 3.40 (3H, s),
2.22 (3H, s), 1.23 (3H, d), 0.95 (3H, d).
2-(Prop-1-yloxy)-ethyl monate A (Compound No 102 of Table 1), a mixture of diastereoisomers.
1H NMR δ(CDCl3) 5.80 (1H, s), 4.23 (2H, t), 3.65 (2H, t), 2.21 (3H, s), 1.60 (2H, t), 1.21 (3H, d), 0.90 (6H, m).
2-Ethoxy-1-methylethyl monate A (Compound No 103 of Table 1)
1H NMR δ(CDCl3) 5.78 (1H, s), 5.09 (1H, m), 2.21 (3H, s), 1.20 (9H, m),
0.93 (3H, d). 2-Cyclopropyloxyethyl monate A (Compound No 104 of Table 1)
1H NMR δ(CDCl3) 5.81 (1H, s), 4.21 (2H, t), 3.72 (2H, t), 2.21 (3H, s),
1.21 (3H, d), 0.95 (3H, d), 0.60 (2H, m), 0.50 (2H, m).
2-Ethoxy-2-methylethyl monate A (Compound No 105 of Table 1), a mixture of diastereoisomers.
1H NMR δ(CDCl3) 5.68 (1H, s), 4.02 (2H, t), 2.21 (3H, s), 1.15 (6H, m), 0.88 (6H, m).
EXAMPLE 88
The following compounds were prepared using the general method of Example 60.
A (5:2) mixture of
i) 2-(hex-1-en-1-yloxy)ethyl monate A (Compound No 34 of Table 1)
1H NMR δ(CDCl3) 5.91 (1H, d), 5.79 (1H, s), 4.38 (1H, q), 2.20 (2H, s),
1.21 (3H, d), 0.92 (3H, d).
and
ii) 2-(1-(vinyl)-but-1-yloxy)ethyl monate A (Compound No 95 of Table 1)
1H NMR δ(CDCl3) 5.79 (1H, s), 5.62 (1H, m), 5.20 (1H, d), 2.20 (2H, s),
1.21 (3H, d), 0.92 (3H, d).
EXAMPLES 89 AND 90
The following compounds were prepared using the general method of Example 38:
N-Methoxymonicamide A (Compound No 106 of Table 1)
1H NMR δ(d6-DMSO) 5.58 (1H, s), 3.70 (3H, s), 2.20 (3H, s), 1.21 (3H, d),
0.95 (3H, d).
N-Ethylmonicamide A (Compound No 62 of Table 1)
1H NMR δ(CDCl3) 5.64 (1H, s), 5.54 (1H, t), 3.33 (2H, q), 2.18 (3H, s), 1.22 (3H, d), 1.17 (3H, t), 0.95 (3H, d).
EXAMPLE 91
This Example illustrates the herbicidal properties of compounds according to the invention.
The herbicidal activity of the compounds was tested as follows:
Each chemical was formulated by dissolving it in an appropriate amount, dependent on the final spray volume, of a solvent/surfactant blend which comprised 78.2 gm/litre of Tween 20 and 21.8 gm/litre of Span 80 adjusted to 1 litre using methylcyclohexanone. Tween 20 is a Trade Mark for a surface-active agent comprising a condensate of 20 molar proportions of ethylene oxide with sorbitan laurate. Span 80 is a Trade Mark for a surface-active agent comprising sorbitan mono-laurate. If the chemical did not dissolve, the volume was made up to 5cm3 with water, glass beads were added and this mixture was then shaken to effect dissolution or suspension of the chemical, after which the beads were removed. In all cases, the mixture was then diluted with water to the required spray volume. If sprayed independently, volumes of 25cm 3 and 30cm3 were required for pre-emergence and post-emergence tests respectively; if sprayed together, 45cm3 was required. The sprayed aqueous emulsion contained 4% of the initial solvent/surfactant mix and the test chemical at an appropriate concentration.
The spray compositions so prepared were sprayed onto young pot plants (post-emergence test) at a spray volume equivalent to 1000 litres per hectare for Compound Numbers 1 to 22 and 400 litres per hectare for
Compound Numbers 23 to 94. Damage to plants was assessed 13 days after spraying by comparison with untreated plants, on a scale of 0 to 9 where 0 is 0% damage, 1 is 1-5% damage, 2 is 6-15% damage, 3 is 16-25% damage, 4 is 26-35% damage, 5 is 36-59% damage, 6 is 60-69% damage, 7 is 70-79% damage, 8 is 80-89% damage and 9 is 90-100% damage.
The designation "-" indicates that a compound was not tested against the indicated species.
The results of the tests are given in Table III below.
TABLE III
Compound Rate of Pre- or TEST PLANTS
No Application Postkg/ha Emergence
Application BV BN GM ZM OS TA PA CA GA AR BP EH IH AT XT AF AM AE SH SV DS EC CE
1 1.0 Post - - - - - - 0 6 5 - - 7 5 6 - 0 3 - - 7 - 4 0
2 1.0 Post 9 6 6 9 5 1 9 8 9 9 9 7 9 8 7 6 2 0 7 9 9 9 6
3 1.0 Post 9 8 7 9 6 4 9 8 9 9 9 7 9 9 9 9 5 5 9 9 9 9 8
4 1.0 Post - - - - - - - 3 - - - - - - - 5 - - - 7 - - -
5 0.883 Post 9 5 8 9 7 1 9 9 9 9 9 8 9 9 9 9 7 5 9 9 9 9 9
6 1.0 Post 0 1 7 7 2 2 9 9 9 9 8 5 9 9 8 5 4. 0 5 9 9 9 7
7 0.773 Post 5 2 5 6 1 1 8 9 7 9 9 5 8 6 6 2 5 0 6 9 9 9 1
8 1.0 Post - - - - - - 9 9 8 - - 9 9 9 - 6 5 - - 9 - 9 4
9 1.0 Post - - - - - - 9 9 9 - - 9 9 9 - 6 3 - - 9 - 9 5
10 1.0 Post 7 2 5 6 1 1 9 9 6 9 9 0 5 4 3 3 4 0 5 9 9 5 0
11 1.0 Post 0 2 5 5 1 1 8 9 7 9 7 0 5 4 5 3 3 0 6 9 9 5 1
12 1.0 Post 1 1 5 8 2 1 8 9 6 9 8 1 5 5 5 1 1 0 5 9 9 6 0
13 1.0 Post 0 1 6 7 1 0 9 9 5 9 7 1 9 5 5 5 2 0 7 9 8 9 1
14 0.967 Post 2 2 6 7 2 1 9 9 6 9 9 5 8 5 8 5 1 0 5 9 9 9 7
TABLE III (Continued)
Compound Rate of Pre- or TEST PLANTS
No Application Postkg/ha Emergence
Application BV BN GM ZM OS TA PA CA GA AR BP EH IH AT XT AF AM AE SH SV PS EC CE
15 1.0 Post 0 0 5 4 0 0 6 8 4 2 3 2 5 3 5 2 1 0 5 5 0 5 1
16 1.0 Post 1 3 3 3 0 0 6 7 2 7 3 1 2 1 5 0 4 0 2 7 5 5 0
17 1.0 Post 0 1 5 7 1 1 9 9 5 9 4 2 5 5 5 1 4 0 3 9 9 8 0
18 1.0 Post 2 1 8 9 3 1 9 9 7 9 9 5 8 6 8 0 2 2 1 9 7 9 1
19 1.0 Post 3 0 8 6 1 1 9 9 6 9 9 4 7 5 8 3 5 1 1 9 9 6 0
20 0.943 Post 2 1 7 1 0 1 8 8 6 7 3 5 6 5 5 0 4 1 1 7 6 5 1
21 1.0 Post 3 0 7 9 6 2 9 9 9 9 9 6 9 9 8 6 6 5 9 9 9 9 8
22 1.0 Post 3 0 7 8 5 1 9 9 8 9 9 6 8 7 9 6 6 4 5 9 9 9 3
TABLE III (continued)
Compound Rate of Pre- or TEST PLANTS
No Application Postkg/ha Emergence
Application BV BN GM ZM TA PA MI CA GA AR EH IH AT XT AF AM LR SH SV BP PD EC CE
23 1.0 Post 9 8 5 5 2 8 9 9 9 9 9 9 9 6 7 6 5 6 9 8 7 9 4
24 1.0 Post 9 9 8 6 4 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 5
25 1.0 Post 9 5 7 3 0 8 9 9 8 9 9 8 5 7 4 0 3 6 9 8 8 5 0
26 1.0 Post 9 7 9 8 3 9 9 9 9 9 8 9 9 7 9 3 6 7 9 9 6 9 5
27 1.0 Post 9 6 9 7 3 9 9 9 9 9 9 9 6 8 8 5 7 8 9 9 9 9 5
28 1.0 Post 9 6 5 1 2 6 9 9 9 9 9 9 3 7 4 0 3 4 9 7 8 9 2
29 1.0 Post 9 9 9 9 6 9 9 9 9 9 8 9 9 9 9 8 5 9 9 9 9 9 6
30 1.0 Post 4 4 9 2 2 7 8 9 5 9 8 7 5 5 2 0 0 4 8 1 2 2 2
31 1.0 Post 7 9 7 5 0 9 9 9 8 9 5 9 8 7 5 3 3 5 9 8 - 6 4
32 1.0 Post 9 8 8 3 3 9 9 9 9 9 9 9 9 9 8 6 3 7 9 7 9 9 3
33 1.0 Post 9 9 9 5 3 9 9 9 9 9 8 9 9 9 8 5 5 7 9 9 9 9 4
35 1.0 Post 9 9 8 7 1 9 9 9 9 9 6 9 9 8 2 0 5 8 9 9 7 6 5
36 1.0 Post 8 8 6 6 0 5 9 9 8 9 5 9 9 4 6 2 3 6 9 8 7 8 3
37 1.0 Post 9 9 9 5 1 9 9 9 9 9 6 9 8 7 8 7 5 6 9 9 9 8 5
TABLE III (continued)
Compound Rate of Pre- or TEST PLANTS
No Application Postkg/ha Emergence
Application BV BN GM ZM TA PA MI CA GA AR EH IH AT XT AF AM LR SH SV BP PD EC CE
38 1.0 Post 5 5 7 2 0 8 9 9 6 9 5 6 7 2 0 0 0 3 7 2 2 0 1
42 1.0 Post 8 9 9 6 5 9 9 9 9 9 - 9 9 8 9 5 5 8 9 9 9 9 5
43 1.0 Post 9 9 9 6 3 9 9 9 9 9 9 9 9 9 9 9 6 6 7 9 9 9 6
44 1.0 Post 9 9 9 6 2 9 9 9 9 9 9 9 9 9 9 6 7 8 9 9 9 9 5
45 1.0 Post 3 4 4 0 1 3 2 5 0 5 1 2 1 1 4 0 1 4 9 3 2 5 0
46 1.0 Post 9 9 9 5 4 9 9 9 7 9 9 9 9 9 7 5 2 8 9 8 7 8 4
47 1.0 Post 9 9 9 6 3 9 9 9 9 9 5 9 9 5 8 3 3 5 9 - 9 8 6
48/49 * 1.0 Post 9 5 9 5 9 2 9 9 9 9 - 9 9 9 8 9 5 - 7 9 - 9 3
50 1.0 Post 2 0 7 3 1 4 6 5 4 5 4 3 6 5 0 2 0 3 5 5 3 4 4
51 1.0 Post 0 1 5 1 1 0 0 1 1 7 0 2 6 2 0 0 0 2 2 0 0 1 0
52 1.0 Post 2 4 6 3 0 5 4 6 0 5 2 3 5 2 0 0 0 1 5 6 2 4 0
53 1.0 Post 0 2 6 2 0 4 3 5 3 5 2 3 6 3 0 1 0 4 2 5 3 2 1
54 1.0 Post 3 2 5 2 0 3 3 5 3 5 5 3 6 5 1 0 0 0 5 5 3 4 0
* Mixture of compounds
TABLE III (continued)
Compound Rate of Pre- or TEST PLANTS
No Application Postkg/ha Emergence
Application BV BN GM ZM TA PA MI CA GA AR EH IH AT XT AF AM LR SH SV BP PD EC CE
55 1.0 Post 3 3 4 3 0 6 9 9 5 9 4 3 5 2 4 1 0 3 9 8 6 5 3
56 1.0 Post 3 3 8 3 2 7 9 9 6 9 6 9 8 7 2 0 0 5 9 3 5 5 4
57 1.0 Post 9 7 6 5 2 8 9 9 8 9 6 9 5 6 6 0 5 5 9 8 7 8 5
58 1.0 Post 2 3 5 2 1 5 3 6 5 0 5 6 0 3 0 1 0 0 5 1 1 0 0
59 1.0 Post 0 0 2 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0
61 1.0 Post 9 9 9 9 5 8 9 9 5 9 9 9 9 8 9 8 5 9 9 - 9 9 5
62 1.0 Post 9 9 9 7 5 9 9 9 9 9 9 9 9 9 9 8 7 9 9 9 9 9 6
64 1.0 Post 9 6 7 4 3 7 6 5 6 9 - 7 6 3 3 6 0 - 6 9 - 9 5
65 1.0 Post 2 9 7 2 1 6 9 7 6 9 8 3 7 9 3 0 3 5 9 8 5 4 0
66 1.0 Post 9 5 9 4 3 6 9 9 6 9 5 5 7 6 5 2 2 2 9 9 7 6 4
67 1.0 Post 7 9 9 5 4 9 9 9 8 9 9 9 9 9 6 5 5 6 9 6 9 9 2
68 1.0 Post 9 5 9 3 2 9 9 9 9 9 6 9 9 9 8 6 6 6 9 9 9 8 5
70 1.0 Post 4 3 6 1 0 9 9 9 5 9 6 9 3 6 0 0 0 2 9 4 5 3 0
74 1.0 Post 2 6 2 2 0 4 8 9 2 9 4 2 4 2 0 0 0 4 9 3 5 6 0
TABLE III (continued)
Compound Rate of Pre- or TEST PLANTS
No Application Postkg/ha Emergence
Application BV BN GM ZM TA PA MI CA GA AR EH IH AT XT ΛF AM LR SH SV BP PD EC CE
75 1.0 Post 2 2 5 1 1 4 5 4 2 8 1 2 2 4 2 0 0 2 5 2 0 2 0
76 1.0 Post 4 3 7 3 2 6 9 9 8 9 4 9 8 6 6 3 7 5 9 8 8 8 3
77 1.0 Post 9 9 9 4 1 9 9 9 9 9 9 9 9 9 7 2 4 3 9 9 7 6 4
78 1.0 Post 9 9 9 6 4 9 9 9 9 9 9 9 9 9 9 8 9 9 9 9 9 9 5
79 1.0 Post 9 5 7 5 0 7 9 9 9 9 6 9 9 9 9 1 0 4 9 5 5 7 5
80 1.0 Post 9 9 7 2 1 9 9 9 9 9 8 9 9 9 5 0 2 4 9 7 7 4 2
81 1.0 Post 7 9 7 2 2 7 6 9 5 9 9 5 7 8 4 4 5 6 7 6 6 5 2
82 1.0 Post 9 9 8 5 5 8 9 9 9 9 9 7 9 9 9 9 8 8 9 9 9 8 5
83 1.0 Post 7 9 9 3 2 7 9 9 5 9 9 3 6 6 6 3 7 4 8 5 7 7 5
93 1.0 Post 9 8 8 6 2 8 9 9 9 9 8 8 8 5 4 3 2 5 9 9 9 5 5
94 1.0 Post 9 9 9 7 2 9 9 9 9 9 9 9 9 9 8 6 6 8 9 9 9 9 3
TABLE IV
Abbreviations used for Test Plants
BV - Sugar beet
BN - Rape
GM - Soybean
ZM - Maize
OS - Rice
TA - Winter wheat
PA - Polygonum aviculare
CA - Chenopodium album
GA - Galium aparine
AR - Amaranthus retroflexus
BP - Bidens pilosa
EH - Euphorbia heterophylla
IH - Ipomoea hederacea (post-emergence)
AT - AbutiIon theophrasti
XT - Xanthium strumarium
AF - Avena fatua
AM - Alopecurus myosuroides
AE - Agropyron repens
SH - Sorghum halepense
SV - Setaria viridis
DS - Digitaria sanguinalis
EC - Echinochloa crus-galli
CE - Cyperus esculentus
MI - Matricaria perforata
LR - Lolium rigidum
PD - Paniucum dicotomifirum
CHEMICAL FORMULAE
(IN DESCRIPTION)
Figure imgf000048_0001
Figure imgf000048_0002
Figure imgf000048_0003
Figure imgf000048_0004
Figure imgf000048_0005
Figure imgf000048_0006
CHEMICAL FORMULAE
(IN DESCRIPTION)
Figure imgf000049_0001
Figure imgf000049_0002
Figure imgf000049_0003
Figure imgf000049_0004
Figure imgf000049_0007
Figure imgf000049_0008
Figure imgf000049_0005
Figure imgf000049_0006
CHEMICAL FORMULAE (IN DESCRIPTION)
Figure imgf000050_0001
Figure imgf000050_0002
Figure imgf000050_0003
Figure imgf000050_0004
Figure imgf000050_0005
CHEMICAL FORMULAE
(IN DESCRIPTION)
Figure imgf000051_0001
Figure imgf000051_0002
Figure imgf000051_0003

Claims

1. A herbicidal composition comprising a compound of the formula (I) or (IA) or (IB) in admixture with a herbicidally acceptable carrier or diluent:-
Figure imgf000052_0001
Figure imgf000052_0002
Figure imgf000052_0003
wherein Y represents
Figure imgf000052_0004
or
Figure imgf000052_0005
or
and wherein R2 is a group CO-XR3 wherein X is 0 or S and R3 is hydrogen or an agrochemically acceptable ester-forming radical; or
R2 is a group -R4 wherein R4 is an optionally substituted aryl or heterocyclic group; or R2 is a group CO-NR5R6 wherein R5 and R6 are the same or different and each represent an agrochemically acceptable amide-forming radical; stereoisomers of the compounds of formula (I),
(IA) and (IB) and salts of the compound of formula (I), (IA) and (IB) wherein R2 is COXR3, X is 0 and R3 is hydrogen.
2. A composition as claimed in claim 1 wherein R2 is a group CO-XR3 and X is oxygen.
3. A composition as claimed in claim 1 or claim 2 wherein R2 is a group CO-XR3 and R3 is optionally substituted C1 to C20 alkyl, optionally substituted C2 to C20 alkenyl, optionally substituted C2 to C20 alkynyl, optionally substituted C3 to C7 cycloalkyl, optionally substituted aryl or optionally substituted heterocyclyl.
4. A composition as claimed in claim 3 wherein the optional substituents which may be present in optionally substituted alkyl, alkenyl or alkynyl groups R3 are C3-7 cycloalkyl, C1-10 alkoxy C1-10 thioalkyl, C2-8 alkenoxy, C2-8 thioalkenyl, C2-8 alkyneoxy, C2-8 thioalkynyl, halogen, halo-C1-10 alkoxy, halo-C2-8alkeneoxy, halo-C2-8alkynoxy, carboxy, C1-6 alkoxycarbonyl, carbamoyl, optionally substituted aryl, optionally substituted heterocyclyl, hydroxy, cyano, nitro,
C1-6alkanoyloxy, amino, mono- and di-(C1-6)alkylamino;
and wherein the optional substituents which may be present in C3-7 cycloalkyl groups, R3 include C1-6alkyl, halo-C1-6alkyl, C1-10 alkoxy,
C1-10 thioalkyl, C2-8 alkenyl, C2-8 alkeneoxy, C2-8 thioalkenyl, C2-8 alkynyl, C2-8 alkyneoxy, C2-8 thioalkynyl, halogen, carboxy, C1-6 alkoxycarbonyl, carbamoyl, optionally substituted aryl, optionally substituted heterocyclyl, hydroxy, cyano, nitro, C1-6alkanoyloxy, amino, mono- and di-(C1-6)alkylamino;
and wherein the optional substituents which may be present in the aryl or heterocyclyl groups are independently selected from halogen, C1-6alkyl, C1-6alkoxy, C1-6thioalkyl, halo(C1-6)alkyl,
hydroxy(C1-6)alkyl, halo(C1-6)alkoxy, C2-8 alkenyl, C2-8 alkeneoxy,
C2-8 thioalkenyl, C2-8 alkynyl, C2-8 alkyneoxy, C2-8 thioalkynyl, hydroxy, cyano, nitro, amino, mono- and di- C1-6 alkylamino, C1-6 alkanesulphinyl, C1-6 alkane sulphonyl, carboxy, C1-6alkoxycarbonyl, and C1-6alkoxycarbonyl(C1-6)alkyl groups.
5. A composition as claimed in claim 3 or claim 4 wherein R3 is C1 to C10 alkyl group which may be unsubstituted or optionally substituted by hydroxy, halogen or cyano.
6. A composition as claimed in claim 3 or claim 4 wherein R3 is a C2 to
C10 alkenyl group which may be unsubstituted or optionally substituted by hydroxy, halogen or cyano.
7. A composition as claimed in claim 1 wherein R2 is a group CO-XR3 and
R3 is a C1-10 alkyl group substituted by a group -A-R11 wherein A is 0 or a group S(0)x wherein x is 0, 1 or 2 and R11 is an optionally substituted C1 to C10 akyl group, an optionally substituted C2 to C8 alkenyl group, an optionally substitued C2 to C8 alkynyl group, an optionally substituted phenyl group, an optionally substituted C1-6 alkyl carbonyl group, an optionally substituted C3-7 cycloalkyl group or an optionally substitututed C3-7 heterocyclic group.
8. A composition as claimed in claim 7 wherein R3 is a C1-4 alkyl group substituted by a group -A-R11 wherein A is 0 or S and R11 is an optionally substituted C1 to C6 akyl group, an optionally substituted
C2 to C6 alkenyl group, an optionally substitued C2 to C6 alkynyl group, an optionally substituted phenyl group, an optionally
substituted C1-6 alkyl carbonyl group, an optionally substituted C3-6 cycloalkyl group or an optionally substituted aliphatic C3-7 oxygen-containing heterocyclic group.
9. A composition as claimed in claim 1 wherein wherein R2 is a group
CO-XR3 and R3 is the group -(CH2)n,-A-CH=CH-R12 wherein n' is an integer from 1 to 4 A is 0 or a group S(0)x wherein x is 0, 1 or 2 and R12 is hydrogen or a C1 to C4 alkyl group.
10. A composition as claimed in claim 1 wherein R2 is a heterocyclic group -R4 and R4 is a group of formula (II):
Figure imgf000055_0001
wherein R14 and R15, which may be the same or different, are
independently selected from hydrogen, optionally substituted phenyl, optionally substituted C1 to C20 alkyl, optionally substituted C2 to
C8 alkenyl, optionally substituted C2 to C8 alkynyl, optionally substituted heterocyclyl or C3 to C7 cycloalkyl, X is a divalent group, -Y'-C=C- and Y' is oxygen or sulphur.
11. A composition as claimed in claim 10 wherein R4 is an optionally
substituted oxazol-2-yl group.
12. A composition as claimed in claim 1 wherein R2 is a group CO-XR3 and
R3 is a group -Z-CO-R8 wherein Z is a C1 to C12 alkylene group and R8 represents an optionally substitued C1-10 alkyl group, an optionally substituted C3-8 cycloalkyl group, an optionally substituted C2-10 alkenyl group, an optionally substituted C2-10 alkynyl group, an optionally substituted aryl group, an optionally substituted aralkyl group, an optionally substituted cycloalkylalkyl group or an
optionally substituted heterocyclyl group.
13. A composition as claimed in claim 1 wherein R2 is a group CO-NR5R6 and wherein R5 and R6 are the same or different and may each independently be:
(a) hydrogen or
(b) an optionally substituted C1-20 alkyl group, an optionally
substituted C2-20 alkenyl group or an optionally substituted
C2-20 alkynyl group or (c) optionally substituted C3 to C7 cycloalkyl or
(d) optionally substituted aryl or
(e) optionally substituted heterocyclyl; or
(f) R5 and R6 together with the nitrogen atom to which they are
attached represent an optionally substituted C5-7 heterocyclic ring or
(g) R5 is hydrogen and R6 is a group -NR22-R23R24 wherein R22 is hydrogen or C1-6 alkyl are R23 and R24, which may be the same or different, may independently take any of the meanings given for R5 and R6 under (a), (b), (c), (d), (e) and (f) above or
(h) R6 is a group -NR22-N=CR23R24 wherein R22, R23 and R24 have the meanings given previously or
(i) R5 is hydrogen and R6 is a group -CR25R26-CO-W or - NR27-CO-W wherein W is optionally substituted phenyl or optionally substituted heterocyclyl, R25, R26 and R27 are indendently hydrogen or optionally substitued C1-6 alkyl groups.
14. A composition according to claim 13 wherein R5 is hydrogen or a C1-4 alkyl group and R6 is a C1-4 alkyl group, each of which alkyl groups may independently be optionally substituted by C3-7 cycloalkyl, C1-4 alkoxy, halogen, carboxy, C1-6 alkoxycarbonyl, carbamyl, optionally substituted aryl, optionally substituted heterocyclyl, hydroxy, C1-6 alkanoyloxy, amino, mono- or di-(C1-6)alkylamino or wherein R5 and R6 together with the nitrogen atom to which they are attached represent an optionally substituted C5-6 aliphatic heterocyclic ring.
15. A composition acording to claim 14 wherein R5 and R6 together with the nitrogen atom to which they are attached represent morpholinyl, piperidyl, piperazinyl, or pyrollidinyl, each of which may be optionally substituted by halogen or C1-4 alkyl.
16. A compound of the formula (I) or (IA) or (IB) in claim 1 wherein R2 is a group CO-XR3 X, is 0 or S and R3 is a C1-10 alkyl group substituted by a group -A-R11 wherein A is 0 or a group S(0)x wherein x is 0, 1 or 2 and R11 is an optionally substituted C1 to C10 alkyl group, an optionally substituted C2 to C8 alkenyl group, an optionally
substituted C2 to C8 alkynyl group, an optionally substituted phenyl group, an optionally substituted C1-6 alkyl carbonyl group, an optionally substituted C3-7 cycloalkyl group or an optionally substitututed C3-7 heterocyclic group, provided that R3 is not a group -(CH2)2- when R11 is ethyl.
17. A compound as claimed in claim 16 wherein R3 is a C1-4 alkyl group substituted by a group -A-R11 wherein A is 0 or a group S(0)x wherein x is 0, 1 or 2 and R11 is an optionally substituted C1 to C6 akyl group, an optionally substituted C2 to C6 alkenyl group, an optionally substitued C2 to C6 alkynyl group, an optionally substituted phenyl group , an optionally substituted C1-6 alkyl carbonyl group, an optionally substituted C3-6 cycloalkyl group or an optionally substituted aliphatic C3-7 oxygen-containing heterocyclic group.
18. A compound as claimed in claim 17 wherein wherein R3 is the group
-(CH2)n,-A-CH=CH-R12 wherein n' is an integer from 1 to 4 A is 0 or a group S(0)x wherein x is 0, 1 or 2 and R12 is hydrogen or a C1 to C4 alkyl group.
19. A compound of formula (VI):
Figure imgf000057_0001
wherein R2 is selected from the group consisting of
-CO-O-CH2CN
-CO-O-CH2-(3-bromophenyl)
-CO-O-CH2-(3-methylphenyl)
-CO-O-CH2-(4-hydroxymethylphenyl)
Figure imgf000057_0002
-CO-O-(CH2)8-Br
Figure imgf000058_0001
-CO-O-(CH2)15CH,
-CO-O-(CH2)2-O-CH2-CH=CH2
-CO-O-(CH2)2-O-CH=CH2-CH3
-CO-O-(CH2)3-CH=CH2
-CO-O-(CH2)2-O-phenyl
-CO-O-(CH2)2-O-(4-chlorophenyl)
-CO-O-(CH2)2-O-CO-CH3
-CO-O-(CH2)2-O-CH2-CO-OC2H5
-CO-O-(CH2)3-C≡CH
-CO-O-(CH2)4-O-CH=CH2
-CO-O-(CH2)3-O-CH=CH2
-CO-O-(CH2)2-O-CH=CH-(CH2)3-CH3
-CO-O-CH-(CH3)2
-CO-O-CH2-C(CH3)3
-CO-O-(cyclohexyl)
-CO-O-(CH2)2-O-(CH2)2-O-CH3
-CO-O-(CH2)2-O-CH2-C≡CH
-CO-O-(CH2)2-O-CH2-CH=CHCl
-CO-O-CH(CH3)-CO-O-C2H5
-CO-O-CH2-CH=CHCl
-CO-O-CH(CH3)-CH=CH2
-CO-O-CH2-CH=CHCH3
-CO-O-(4-chlorophenyl)
-CO-O-(3-nitrophenyl)
-CO-O-(4-methoxyphenyl)
-CO-O-CH2-(furan-2-yl)
-CO-O-CH2-CH2Cl
-CO-NH-(2,4-dichlorophenyl)
-CO-NH-(2,5-dichloropheny1)
-CO-N(CH3)-(2,4-dichlorophenyl)
-CO-NH-C2H5 -CO-NH-CH2-CO-OC2H5
-CO-O-(CH2)2-S-CH=CH2
-CO-S-(CH2)2-O-CH=CH2
-CO-O-CH2-O-CH=CH2
-CO-O-(CH2)9CH3
-CO-O-CH2-O-C2H5
-CO-NH-(CH2)2-OH
-CO-NH-(CH2)2-O-C2H5
-CO-N(-CH2-CH=CH2)2
-CO-NH-N(CH3)2
Figure imgf000059_0001
-CO-NH-N=C(CH3)2
Figure imgf000059_0002
-CO-N(CH2-CH2-OH)2
-CO-O- (CH3)3S+
-CO-O-CH2-cyclopropyl
-CO-O-(CH2)2-O-CH2-CH=CH-CH2-CH2-CH3 -CO-O-(CH2)2-O-C(C3H7)-CH=CH2
-CO-O-CH2-CH2-O-CH(CH3)-CH3
-CO-O-CH2-CH2-O-CH3
-CO-O-CH2-CH2-O-CH2-CH2-CH3
-CO-O-CH(CH3)-CH2-O-CH2-CH3
-CO-O-CH2-CH2-O-(cyclopropyl)
-CO-O-CH2-CH(CH3)-O-CH2-CH3
-CO-NH-OCH3
20. A compound of formula (IB):
Figure imgf000060_0001
wherein R2 is selected from the group consisting of
-CO-O-CH2-CH2-O-CH=CH2
-CO-O-C2H5
-CO-O-(CH2)2-OH
-CO-O-CH2-CH2-O-C2H5
21. A process of severely damaging or killing unwanted plants, which
comprises applying to the plants or to the growth medium of the plants a herbicidally effective amount of a compound of the formula (I) or (IA) or (IB) in claim 1 wherein R2 is as defined in any of claims 1 to
15 or a herbicidally effective amount of a compound as claimed in any of claims 16 to 19.
PCT/GB1993/000542 1992-04-07 1993-03-16 Herbicides WO1993019599A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP93906681A EP0634895A1 (en) 1992-04-07 1993-03-16 Herbicides

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB929207542A GB9207542D0 (en) 1992-04-07 1992-04-07 Herbicides
GB9207542.3 1992-04-07
GB9226733.5 1992-12-22
GB929226733A GB9226733D0 (en) 1992-12-22 1992-12-22 Herbicides

Publications (1)

Publication Number Publication Date
WO1993019599A1 true WO1993019599A1 (en) 1993-10-14

Family

ID=26300664

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1993/000542 WO1993019599A1 (en) 1992-04-07 1993-03-16 Herbicides

Country Status (12)

Country Link
EP (1) EP0634895A1 (en)
CN (1) CN1079965A (en)
AU (1) AU3759193A (en)
BG (1) BG97605A (en)
CA (1) CA2132746A1 (en)
GB (1) GB9305238D0 (en)
IL (1) IL105272A0 (en)
MA (1) MA22867A1 (en)
TR (1) TR27245A (en)
UY (1) UY23567A1 (en)
WO (1) WO1993019599A1 (en)
ZW (1) ZW4393A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2282537A (en) * 1993-10-06 1995-04-12 Zeneca Ltd Herbicidal compositions containing ketones derived from monic acid
EP3772514A1 (en) 2019-08-08 2021-02-10 Basf Se Herbicidal amides

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9320563D0 (en) * 1993-10-06 1993-11-24 Zeneca Ltd Assay procedure and application in identification of herbicides

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1587058A (en) * 1976-06-15 1981-03-25 Beecham Group Ltd Oxiranylmethyltetrahydropyran derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA814257B (en) * 1980-06-24 1983-02-23 Beecham Group Plc Treating plant infections

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1587058A (en) * 1976-06-15 1981-03-25 Beecham Group Ltd Oxiranylmethyltetrahydropyran derivatives

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CENTRAL PATENTS INDEX, BASIC ABSTRACTS JOURNAL Section Ch, Week 8317, 22 June 1983 Derwent Publications Ltd., London, GB; Class C, AN 41575K *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2282537A (en) * 1993-10-06 1995-04-12 Zeneca Ltd Herbicidal compositions containing ketones derived from monic acid
EP3772514A1 (en) 2019-08-08 2021-02-10 Basf Se Herbicidal amides
WO2021023572A1 (en) 2019-08-08 2021-02-11 Basf Se Herbicidal amides

Also Published As

Publication number Publication date
AU3759193A (en) 1993-11-08
CA2132746A1 (en) 1993-10-14
BG97605A (en) 1994-06-30
EP0634895A1 (en) 1995-01-25
ZW4393A1 (en) 1993-11-24
IL105272A0 (en) 1993-08-18
MA22867A1 (en) 1993-12-31
UY23567A1 (en) 1993-04-21
GB9305238D0 (en) 1993-05-05
CN1079965A (en) 1993-12-29
TR27245A (en) 1994-12-21

Similar Documents

Publication Publication Date Title
US5856273A (en) Herbicidally active phenylsubstituted 5-and 6-membered heterocyclic compounds
GB2253848A (en) Heterocyclic compounds
EP0447055A1 (en) 3-(Substituted phenyl)pyrazole derivatives, a process for producing the same, herbicidal composition containing the same and method of controlling weeds using said composition
DE69837621T2 (en) SUBSTITUTED PYRIMIDINES AND PYRIDINES AS WEED CONTROLS
US5863865A (en) Herbicidal 4-benzoylisoxazoles derivatives
GB2237570A (en) Hydrazide and hydroxylamine herbicides
GB2276379A (en) Herbicidal compounds having a pentafluorosulphanyl group
US5726129A (en) Pyrrolidine-2-thione derivatives as herbicides
US5565413A (en) Substituted pyridyl phenyl ketone herbicides
WO1993019599A1 (en) Herbicides
US5234895A (en) Arylpyridone herbicides
US5763357A (en) 3-substituted pyridine compounds and derivatives thereof
US5466662A (en) Use of 4-chloro-3-(4-chloro-2-fluorophenyl)-5-difluoromethoxy-1-methyl-1H-pyrazole as an herbicidal treatment
US5512537A (en) 2-benzoyl pyrrole and benzoyl imidazole herbicides
US5670453A (en) Herbicidal hydroxybenzyl-substituted heteroaryl compounds and derivatives thereof
AU7790194A (en) Herbicidal aza bisphosphonic acid compositions
EP0927169A1 (en) 4-cycloalkyl-5-substituted pyrimidine compounds useful as crop protection agents
US5681795A (en) 3-benzoyl pyrrole and pyrazole herbicides
US5167696A (en) Herbicidal aryloxy- and arylamino-indanes
GB2282537A (en) Herbicidal compositions containing ketones derived from monic acid
GB2282538A (en) Herbicidal compositions
US6197766B1 (en) Insecticidal dihydrooxadiazine compounds
GB2282536A (en) Herbicidal compositions
US5190574A (en) Herbicidal pyrazolyloxy and pyrazolylamino-benzotriazoles
US5714438A (en) Herbicidal 5-substituted pyrimidine compounds and derivatives thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AT AU BB BG BR CA CH CZ DE DK ES FI GB HU JP KP KR LK LU MG MN MW NL NO NZ PL PT RO RU SD SE SK UA US VN

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1993906681

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2132746

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 249916

Country of ref document: NZ

WWP Wipo information: published in national office

Ref document number: 1993906681

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1993906681

Country of ref document: EP